AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|200930811|Female|All other|2007-2011|~|~|~
0-19|~|~|~|Malignant|~|200930811|Female|All other|2007-2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40630177|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|40630177|Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40094103|Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|40094103|Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|39865121|Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40165421|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40382360|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Anaplastic astrocytoma|2007-2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|169|200930811|Female|Anaplastic astrocytoma|2007-2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40670476|Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40630177|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40094103|Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Anaplastic oligodendroglioma|2007-2011|~|~|~
0-19|~|~|~|Malignant|~|200930811|Female|Anaplastic oligodendroglioma|2007-2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40630177|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40094103|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|39865121|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|39998876|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|40165421|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|40382360|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Astrocytoma, NOS|2007-2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|428|200930811|Female|Astrocytoma, NOS|2007-2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|84|40576293|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40670476|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|40630177|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|78|40094103|Female|Astrocytoma, NOS|2011|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|28|39865121|Female|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|39998876|Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40382360|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|146|200930811|Female|Choroid plexus|2007-2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|40|200930811|Female|Choroid plexus|2007-2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40670476|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40630177|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40630177|Female|Choroid plexus|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40094103|Female|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40094103|Female|Choroid plexus|2011|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|80|39865121|Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|39998876|Female|Craniopharyngioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|40165421|Female|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|40382360|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|415|200930811|Female|Craniopharyngioma|2007-2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|200930811|Female|Craniopharyngioma|2007-2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|62|40576293|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|88|40630177|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40630177|Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|40094103|Female|Craniopharyngioma|2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40094103|Female|Craniopharyngioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Diffuse astrocytoma|2007-2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|83|200930811|Female|Diffuse astrocytoma|2007-2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40630177|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40094103|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|216|39865121|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|184|39998876|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|202|40165421|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.5|Malignant|218|40382360|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Embryonal/primitive/medulloblastoma|2007-2011|~|~|~
0-19|0.5|0.5|0.5|Malignant|1004|200930811|Female|Embryonal/primitive/medulloblastoma|2007-2011|0.5|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.7|0.6|Malignant|233|40576293|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|199|40670476|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|175|40630177|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.4|0.5|0.5|Malignant|189|40094103|Female|Embryonal/primitive/medulloblastoma|2011|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|63|200930811|Female|Ependymoma variants|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|200930811|Female|Ependymoma variants|2007-2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|40630177|Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40094103|Female|Ependymoma variants|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40094103|Female|Ependymoma variants|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|39865121|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|39998876|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40165421|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40382360|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Ependymoma/anaplastic ependymoma|2007-2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|410|200930811|Female|Ependymoma/anaplastic ependymoma|2007-2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|40576293|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40670476|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40630177|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|40094103|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Germ Cell Tumors|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|35|40382360|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|87|200930811|Female|Germ Cell Tumors|2007-2011|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|192|200930811|Female|Germ Cell Tumors|2007-2011|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|27|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|20|40670476|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|40|40670476|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40630177|Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|52|40630177|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40094103|Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|38|40094103|Female|Germ Cell Tumors|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|53|39865121|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|39998876|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40165421|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|60|40382360|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Glioblastoma|2007-2011|~|~|~
0-19|0.1|0.2|0.1|Malignant|281|200930811|Female|Glioblastoma|2007-2011|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40670476|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|50|40630177|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Glioblastoma|2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40094103|Female|Glioblastoma|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|230|39865121|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|227|39998876|Female|Glioma malignant, NOS|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|243|40165421|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.7|Malignant|260|40382360|Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|43|200930811|Female|Glioma malignant, NOS|2007-2011|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|1333|200930811|Female|Glioma malignant, NOS|2007-2011|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|264|40576293|Female|Glioma malignant, NOS|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.8|0.7|Malignant|289|40670476|Female|Glioma malignant, NOS|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.5|0.7|0.6|Malignant|238|40630177|Female|Glioma malignant, NOS|2010|0.5|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|19|40094103|Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|285|40094103|Female|Glioma malignant, NOS|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39998876|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40382360|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|61|200930811|Female|Hemangioblastoma|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|200930811|Female|Hemangioblastoma|2007-2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|40630177|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40094103|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|39998876|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|40165421|Female|Hemangioma|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40382360|Female|Hemangioma|2007|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|204|200930811|Female|Hemangioma|2007-2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|200930811|Female|Hemangioma|2007-2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|40576293|Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|40670476|Female|Hemangioma|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|40630177|Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40630177|Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|57|40094103|Female|Hemangioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40094103|Female|Hemangioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Local Extensions from Regional Tumors|2007-2011|~|~|~
0-19|~|~|~|Malignant|~|200930811|Female|Local Extensions from Regional Tumors|2007-2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|40630177|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|40094103|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Lymphomas and Hematopoietic Neoplasms|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|200930811|Female|Lymphomas and Hematopoietic Neoplasms|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|40630177|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|40094103|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|39865121|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|39998876|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|40165421|Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40382360|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|289|200930811|Female|Meningioma|2007-2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|200930811|Female|Meningioma|2007-2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|40576293|Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|57|40670476|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|40630177|Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40630177|Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|62|40094103|Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40094103|Female|Meningioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|39998876|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40382360|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Mixed glioma|2007-2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|82|200930811|Female|Mixed glioma|2007-2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40576293|Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40630177|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40094103|Female|Mixed glioma|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|39865121|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|39865121|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|52|39998876|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|39998876|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|48|40165421|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|46|40382360|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|319|200930811|Female|Neoplasm, unspecified|2007-2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|82|200930811|Female|Neoplasm, unspecified|2007-2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|72|40576293|Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|40576293|Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|57|40670476|Female|Neoplasm, unspecified|2009|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|40670476|Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|82|40630177|Female|Neoplasm, unspecified|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40630177|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40094103|Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|21|40094103|Female|Neoplasm, unspecified|2011|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|101|39865121|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|143|39998876|Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|40165421|Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|40382360|Female|Nerve sheath, benign and malignant|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|564|200930811|Female|Nerve sheath, benign and malignant|2007-2011|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|200930811|Female|Nerve sheath, benign and malignant|2007-2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|119|40576293|Female|Nerve sheath, benign and malignant|2008|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|124|40670476|Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|104|40630177|Female|Nerve sheath, benign and malignant|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40630177|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|104|40094103|Female|Nerve sheath, benign and malignant|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40094103|Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Neuroepithelial|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|200930811|Female|Neuroepithelial|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|40630177|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|40094103|Female|Neuroepithelial|2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|39865121|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|21|39865121|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|136|39998876|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|119|40165421|Female|Neuronal/glial, neuronal|2006|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|134|40382360|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|30|40382360|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|665|200930811|Female|Neuronal/glial, neuronal|2007-2011|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|103|200930811|Female|Neuronal/glial, neuronal|2007-2011|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|127|40576293|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|40576293|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|130|40670476|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40670476|Female|Neuronal/glial, neuronal|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|40630177|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|19|40630177|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|134|40094103|Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40094103|Female|Neuronal/glial, neuronal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|28|40382360|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Oligodendroglioma|2007-2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|102|200930811|Female|Oligodendroglioma|2007-2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40576293|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|40630177|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40094103|Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|39998876|Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40165421|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40382360|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|99|200930811|Female|Other mesenchymal|2007-2011|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Malignant|34|200930811|Female|Other mesenchymal|2007-2011|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|16|40576293|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|40670476|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40630177|Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40630177|Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40094103|Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40094103|Female|Other mesenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|323|39865121|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|315|39998876|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|307|40165421|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|328|40382360|Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|200930811|Female|Pilocytic astrocytoma|2007-2011|~|~|~
0-19|0.8|0.9|0.8|Malignant|1677|200930811|Female|Pilocytic astrocytoma|2007-2011|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|324|40576293|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.7|0.9|0.8|Malignant|335|40670476|Female|Pilocytic astrocytoma|2009|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|368|40630177|Female|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.7|0.9|0.8|Malignant|331|40094103|Female|Pilocytic astrocytoma|2011|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|200930811|Female|Pineal parenchymal|2007-2011|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|70|200930811|Female|Pineal parenchymal|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40576293|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40630177|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|40630177|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Malignant|~|40094103|Female|Pineal parenchymal|2011|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|239|39865121|Female|Pituitary|2004|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|277|39998876|Female|Pituitary|2005|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|305|40165421|Female|Pituitary|2006|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|297|40382360|Female|Pituitary|2007|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007|~|~|~
0-19|0.8|0.8|0.8|Benign/Borderline|1644|200930811|Female|Pituitary|2007-2011|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|200930811|Female|Pituitary|2007-2011|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|328|40576293|Female|Pituitary|2008|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|326|40670476|Female|Pituitary|2009|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|375|40630177|Female|Pituitary|2010|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40630177|Female|Pituitary|2010|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|324|40094103|Female|Pituitary|2011|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40094103|Female|Pituitary|2011|~|~|~
0-19|1.7|1.9|1.8|Benign/Borderline|727|39865121|Female|Total|2004|1.7|2.0|1.8
0-19|3.1|3.4|3.2|Malignant|1290|39865121|Female|Total|2004|3.1|3.4|3.2
0-19|2.0|2.3|2.2|Benign/Borderline|877|39998876|Female|Total|2005|2.0|2.3|2.2
0-19|2.9|3.2|3.0|Malignant|1214|39998876|Female|Total|2005|2.9|3.2|3.0
0-19|2.0|2.3|2.1|Benign/Borderline|872|40165421|Female|Total|2006|2.0|2.3|2.2
0-19|2.9|3.2|3.0|Malignant|1208|40165421|Female|Total|2006|2.8|3.2|3.0
0-19|2.0|2.3|2.2|Benign/Borderline|897|40382360|Female|Total|2007|2.1|2.4|2.2
0-19|3.0|3.4|3.2|Malignant|1281|40382360|Female|Total|2007|3.0|3.4|3.2
0-19|2.3|2.4|2.3|Benign/Borderline|4752|200930811|Female|Total|2007-2011|2.3|2.4|2.4
0-19|3.1|3.2|3.1|Malignant|6280|200930811|Female|Total|2007-2011|3.0|3.2|3.1
0-19|2.1|2.4|2.3|Benign/Borderline|936|40576293|Female|Total|2008|2.2|2.5|2.3
0-19|2.9|3.3|3.1|Malignant|1258|40576293|Female|Total|2008|2.9|3.3|3.1
0-19|2.2|2.5|2.3|Benign/Borderline|955|40670476|Female|Total|2009|2.2|2.5|2.3
0-19|2.9|3.3|3.1|Malignant|1253|40670476|Female|Total|2009|2.9|3.3|3.1
0-19|2.3|2.6|2.5|Benign/Borderline|1014|40630177|Female|Total|2010|2.3|2.7|2.5
0-19|2.9|3.3|3.1|Malignant|1246|40630177|Female|Total|2010|2.9|3.2|3.1
0-19|2.2|2.5|2.4|Benign/Borderline|961|40094103|Female|Total|2011|2.2|2.6|2.4
0-19|3.0|3.4|3.2|Malignant|1275|40094103|Female|Total|2011|3.0|3.4|3.2
0-19|0.2|0.3|0.3|Benign/Borderline|101|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|143|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|565|200930811|Female|Tumors of Cranial and Spinal Nerves|2007-2011|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|200930811|Female|Tumors of Cranial and Spinal Nerves|2007-2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|119|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|124|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|104|40630177|Female|Tumors of Cranial and Spinal Nerves|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40630177|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|105|40094103|Female|Tumors of Cranial and Spinal Nerves|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40094103|Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|183|39865121|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|2.8|3.2|3.0|Malignant|1193|39865121|Female|Tumors of Neuroepthelial Tissue|2004|2.8|3.2|3.0
0-19|0.4|0.5|0.5|Benign/Borderline|191|39998876|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.6|0.5
0-19|2.7|3.0|2.8|Malignant|1124|39998876|Female|Tumors of Neuroepthelial Tissue|2005|2.6|3.0|2.8
0-19|0.4|0.6|0.5|Benign/Borderline|195|40165421|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.0|2.9|Malignant|1141|40165421|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.0|2.8
0-19|0.5|0.6|0.5|Benign/Borderline|222|40382360|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.5
0-19|2.9|3.2|3.0|Malignant|1215|40382360|Female|Tumors of Neuroepthelial Tissue|2007|2.8|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|1067|200930811|Female|Tumors of Neuroepthelial Tissue|2007-2011|0.5|0.6|0.5
0-19|2.9|3.0|3.0|Malignant|5920|200930811|Female|Tumors of Neuroepthelial Tissue|2007-2011|2.9|3.0|2.9
0-19|0.5|0.6|0.5|Benign/Borderline|213|40576293|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
0-19|2.8|3.1|3.0|Malignant|1204|40576293|Female|Tumors of Neuroepthelial Tissue|2008|2.8|3.1|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|197|40670476|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1171|40670476|Female|Tumors of Neuroepthelial Tissue|2009|2.7|3.0|2.9
0-19|0.5|0.6|0.5|Benign/Borderline|217|40630177|Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.5
0-19|2.7|3.0|2.9|Malignant|1165|40630177|Female|Tumors of Neuroepthelial Tissue|2010|2.7|3.0|2.9
0-19|0.5|0.6|0.5|Benign/Borderline|220|40094103|Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.5
0-19|2.8|3.2|3.0|Malignant|1197|40094103|Female|Tumors of Neuroepthelial Tissue|2011|2.8|3.2|3.0
0-19|0.7|0.9|0.8|Benign/Borderline|319|39865121|Female|Tumors of Sellar Region|2004|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|352|39998876|Female|Tumors of Sellar Region|2005|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|380|40165421|Female|Tumors of Sellar Region|2006|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|392|40382360|Female|Tumors of Sellar Region|2007|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007|~|~|~
0-19|1.0|1.0|1.0|Benign/Borderline|2059|200930811|Female|Tumors of Sellar Region|2007-2011|1.0|1.1|1.0
0-19|~|~|~|Malignant|~|200930811|Female|Tumors of Sellar Region|2007-2011|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|390|40576293|Female|Tumors of Sellar Region|2008|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|417|40670476|Female|Tumors of Sellar Region|2009|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|463|40630177|Female|Tumors of Sellar Region|2010|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40630177|Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|404|40094103|Female|Tumors of Sellar Region|2011|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40094103|Female|Tumors of Sellar Region|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|39865121|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|102|39998876|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|40165421|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|40382360|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|449|200930811|Female|Tumors of the Meninges|2007-2011|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|47|200930811|Female|Tumors of the Meninges|2007-2011|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|85|40576293|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|40670476|Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40630177|Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40630177|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|40094103|Female|Tumors of the Meninges|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40094103|Female|Tumors of the Meninges|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|39865121|Female|Unclassified Tumors|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|39865121|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|75|39998876|Female|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|73|40165421|Female|Unclassified Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|69|40382360|Female|Unclassified Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|523|200930811|Female|Unclassified Tumors|2007-2011|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|86|200930811|Female|Unclassified Tumors|2007-2011|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|110|40576293|Female|Unclassified Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|16|40576293|Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|102|40670476|Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|21|40670476|Female|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|123|40630177|Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40630177|Female|Unclassified Tumors|2010|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|120|40094103|Female|Unclassified Tumors|2011|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|21|40094103|Female|Unclassified Tumors|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|21|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|23|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|34|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|114|200930811|Female|Unique astrocytoma variants|2007-2011|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|96|200930811|Female|Unique astrocytoma variants|2007-2011|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|20|40576293|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|17|40630177|Female|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40630177|Female|Unique astrocytoma variants|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40094103|Female|Unique astrocytoma variants|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|40094103|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|16|210572387|Male|All other|2007-2011|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|28|210572387|Male|All other|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550805|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|42550805|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42001185|Male|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|42001185|Male|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42158997|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|53|42367071|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Anaplastic astrocytoma|2007-2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|209|210572387|Male|Anaplastic astrocytoma|2007-2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|42541971|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|42550805|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|42001185|Male|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Anaplastic oligodendroglioma|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|210572387|Male|Anaplastic oligodendroglioma|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|42550805|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42001185|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|41889233|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42006384|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|42158997|Male|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42367071|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Astrocytoma, NOS|2007-2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|517|210572387|Male|Astrocytoma, NOS|2007-2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|42541971|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|106|42609915|Male|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|119|42550805|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|100|42001185|Male|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42006384|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42367071|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|173|210572387|Male|Choroid plexus|2007-2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|52|210572387|Male|Choroid plexus|2007-2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|35|42541971|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42550805|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42550805|Male|Choroid plexus|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|42001185|Male|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42001185|Male|Choroid plexus|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|82|41889233|Male|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|88|42006384|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|42158997|Male|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42367071|Male|Craniopharyngioma|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|396|210572387|Male|Craniopharyngioma|2007-2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|210572387|Male|Craniopharyngioma|2007-2011|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|42541971|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|78|42609915|Male|Craniopharyngioma|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|42550805|Male|Craniopharyngioma|2010|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42550805|Male|Craniopharyngioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|42001185|Male|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42001185|Male|Craniopharyngioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41889233|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Diffuse astrocytoma|2007-2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|97|210572387|Male|Diffuse astrocytoma|2007-2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|42541971|Male|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42550805|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|42001185|Male|Diffuse astrocytoma|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|292|41889233|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.7|0.7|Malignant|275|42006384|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|293|42158997|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|298|42367071|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Embryonal/primitive/medulloblastoma|2007-2011|~|~|~
0-19|0.7|0.8|0.7|Malignant|1522|210572387|Male|Embryonal/primitive/medulloblastoma|2007-2011|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.8|0.7|Malignant|316|42541971|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.8|0.7|Malignant|305|42609915|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|313|42550805|Male|Embryonal/primitive/medulloblastoma|2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|295|42001185|Male|Embryonal/primitive/medulloblastoma|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42367071|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|104|210572387|Male|Ependymoma variants|2007-2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|210572387|Male|Ependymoma variants|2007-2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42609915|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42550805|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42550805|Male|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42001185|Male|Ependymoma variants|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42001185|Male|Ependymoma variants|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41889233|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|104|42006384|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|42158997|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|113|42367071|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Ependymoma/anaplastic ependymoma|2007-2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|548|210572387|Male|Ependymoma/anaplastic ependymoma|2007-2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42541971|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42609915|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|118|42550805|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|112|42001185|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|105|41889233|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|20|42006384|Male|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|85|42006384|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|26|42158997|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|42367071|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|97|42367071|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|92|210572387|Male|Germ Cell Tumors|2007-2011|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|514|210572387|Male|Germ Cell Tumors|2007-2011|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|18|42541971|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|115|42541971|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|42609915|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|97|42609915|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42550805|Male|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|110|42550805|Male|Germ Cell Tumors|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Germ Cell Tumors|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42001185|Male|Germ Cell Tumors|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|73|41889233|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|65|42158997|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42367071|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Glioblastoma|2007-2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|363|210572387|Male|Glioblastoma|2007-2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|65|42541971|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|42609915|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42550805|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|42001185|Male|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|228|41889233|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|214|42006384|Male|Glioma malignant, NOS|2005|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.6|0.6|Malignant|233|42158997|Male|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|240|42367071|Male|Glioma malignant, NOS|2007|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|40|210572387|Male|Glioma malignant, NOS|2007-2011|0.0|0.0|0.0
0-19|0.6|0.6|0.6|Malignant|1252|210572387|Male|Glioma malignant, NOS|2007-2011|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.5|0.7|0.6|Malignant|258|42541971|Male|Glioma malignant, NOS|2008|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.5|0.7|0.6|Malignant|258|42609915|Male|Glioma malignant, NOS|2009|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.5|0.7|0.6|Malignant|255|42550805|Male|Glioma malignant, NOS|2010|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Glioma malignant, NOS|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|241|42001185|Male|Glioma malignant, NOS|2011|0.5|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42367071|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|79|210572387|Male|Hemangioblastoma|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|210572387|Male|Hemangioblastoma|2007-2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42550805|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42001185|Male|Hemangioblastoma|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42001185|Male|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|41889233|Male|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|42006384|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|31|42158997|Male|Hemangioma|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|42367071|Male|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|233|210572387|Male|Hemangioma|2007-2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|210572387|Male|Hemangioma|2007-2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|42541971|Male|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42609915|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|48|42550805|Male|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42550805|Male|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|57|42001185|Male|Hemangioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42001185|Male|Hemangioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Local Extensions from Regional Tumors|2007-2011|~|~|~
0-19|~|~|~|Malignant|~|210572387|Male|Local Extensions from Regional Tumors|2007-2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|42550805|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|42001185|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Lymphomas and Hematopoietic Neoplasms|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|41|210572387|Male|Lymphomas and Hematopoietic Neoplasms|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|42550805|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|42001185|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|41889233|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42006384|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|49|42158997|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|49|42367071|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|267|210572387|Male|Meningioma|2007-2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|18|210572387|Male|Meningioma|2007-2011|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|52|42541971|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|42609915|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|49|42550805|Male|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42550805|Male|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|42001185|Male|Meningioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42001185|Male|Meningioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Mixed glioma|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|65|210572387|Male|Mixed glioma|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42550805|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42001185|Male|Mixed glioma|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Neoplasm, unspecified|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42006384|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|42006384|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|49|42158997|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|42158997|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|62|42367071|Male|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|326|210572387|Male|Neoplasm, unspecified|2007-2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|101|210572387|Male|Neoplasm, unspecified|2007-2011|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|44|42541971|Male|Neoplasm, unspecified|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|42541971|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|86|42609915|Male|Neoplasm, unspecified|2009|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|74|42550805|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|18|42550805|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|60|42001185|Male|Neoplasm, unspecified|2011|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|42001185|Male|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|116|41889233|Male|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|112|42006384|Male|Nerve sheath, benign and malignant|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|42158997|Male|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|42367071|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|622|210572387|Male|Nerve sheath, benign and malignant|2007-2011|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|210572387|Male|Nerve sheath, benign and malignant|2007-2011|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|126|42541971|Male|Nerve sheath, benign and malignant|2008|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|42609915|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|109|42550805|Male|Nerve sheath, benign and malignant|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42550805|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|112|42001185|Male|Nerve sheath, benign and malignant|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42001185|Male|Nerve sheath, benign and malignant|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Neuroepithelial|2007-2011|~|~|~
0-19|~|~|~|Malignant|~|210572387|Male|Neuroepithelial|2007-2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|42550805|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|42001185|Male|Neuroepithelial|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|146|41889233|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|156|42006384|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|153|42158997|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|42158997|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|167|42367071|Male|Neuronal/glial, neuronal|2007|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.4|0.4|0.4|Benign/Borderline|823|210572387|Male|Neuronal/glial, neuronal|2007-2011|0.4|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|107|210572387|Male|Neuronal/glial, neuronal|2007-2011|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|167|42541971|Male|Neuronal/glial, neuronal|2008|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|28|42541971|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|158|42609915|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Neuronal/glial, neuronal|2009|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|161|42550805|Male|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42550805|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|173|42001185|Male|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|19|42001185|Male|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|41889233|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|28|42006384|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42158997|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Oligodendroglioma|2007-2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|115|210572387|Male|Oligodendroglioma|2007-2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|30|42541971|Male|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42609915|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|21|42550805|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42001185|Male|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42006384|Male|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|95|210572387|Male|Other mesenchymal|2007-2011|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Malignant|24|210572387|Male|Other mesenchymal|2007-2011|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|18|42541971|Male|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42550805|Male|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42550805|Male|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42001185|Male|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42001185|Male|Other mesenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|365|41889233|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|342|42006384|Male|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|1.0|0.9|Malignant|359|42158997|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|340|42367071|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Pilocytic astrocytoma|2007-2011|~|~|~
0-19|0.8|0.9|0.9|Malignant|1787|210572387|Male|Pilocytic astrocytoma|2007-2011|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|380|42541971|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.8|Malignant|354|42609915|Male|Pilocytic astrocytoma|2009|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|0.9|0.8|Malignant|357|42550805|Male|Pilocytic astrocytoma|2010|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|366|42001185|Male|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367071|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|210572387|Male|Pineal parenchymal|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|78|210572387|Male|Pineal parenchymal|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42541971|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550805|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|42550805|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42001185|Male|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42001185|Male|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|82|41889233|Male|Pituitary|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|42006384|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|86|42158997|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42367071|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|617|210572387|Male|Pituitary|2007-2011|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|210572387|Male|Pituitary|2007-2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|121|42541971|Male|Pituitary|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|42609915|Male|Pituitary|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|117|42550805|Male|Pituitary|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42550805|Male|Pituitary|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|123|42001185|Male|Pituitary|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42001185|Male|Pituitary|2011|~|~|~
0-19|1.4|1.7|1.5|Benign/Borderline|649|41889233|Male|Total|2004|1.4|1.7|1.5
0-19|3.4|3.7|3.6|Malignant|1487|41889233|Male|Total|2004|3.4|3.7|3.5
0-19|1.6|1.9|1.7|Benign/Borderline|739|42006384|Male|Total|2005|1.6|1.9|1.8
0-19|3.2|3.5|3.4|Malignant|1401|42006384|Male|Total|2005|3.2|3.5|3.3
0-19|1.6|1.9|1.8|Benign/Borderline|752|42158997|Male|Total|2006|1.7|1.9|1.8
0-19|3.4|3.7|3.5|Malignant|1490|42158997|Male|Total|2006|3.4|3.7|3.5
0-19|1.7|2.0|1.9|Benign/Borderline|797|42367071|Male|Total|2007|1.8|2.0|1.9
0-19|3.4|3.7|3.6|Malignant|1499|42367071|Male|Total|2007|3.4|3.7|3.5
0-19|1.8|2.0|1.9|Benign/Borderline|4027|210572387|Male|Total|2007-2011|1.9|2.0|1.9
0-19|3.5|3.7|3.6|Malignant|7583|210572387|Male|Total|2007-2011|3.5|3.7|3.6
0-19|1.7|1.9|1.8|Benign/Borderline|773|42541971|Male|Total|2008|1.7|1.9|1.8
0-19|3.5|3.9|3.7|Malignant|1566|42541971|Male|Total|2008|3.5|3.9|3.7
0-19|1.9|2.2|2.0|Benign/Borderline|870|42609915|Male|Total|2009|1.9|2.2|2.0
0-19|3.4|3.8|3.6|Malignant|1519|42609915|Male|Total|2009|3.4|3.7|3.6
0-19|1.7|2.0|1.9|Benign/Borderline|796|42550805|Male|Total|2010|1.7|2.0|1.9
0-19|3.5|3.8|3.6|Malignant|1544|42550805|Male|Total|2010|3.4|3.8|3.6
0-19|1.8|2.0|1.9|Benign/Borderline|798|42001185|Male|Total|2011|1.8|2.0|1.9
0-19|3.4|3.7|3.5|Malignant|1486|42001185|Male|Total|2011|3.4|3.7|3.5
0-19|0.2|0.3|0.3|Benign/Borderline|116|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|112|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|622|210572387|Male|Tumors of Cranial and Spinal Nerves|2007-2011|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|210572387|Male|Tumors of Cranial and Spinal Nerves|2007-2011|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|126|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|109|42550805|Male|Tumors of Cranial and Spinal Nerves|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42550805|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|112|42001185|Male|Tumors of Cranial and Spinal Nerves|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42001185|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|224|41889233|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.1|3.4|3.2|Malignant|1348|41889233|Male|Tumors of Neuroepthelial Tissue|2004|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|252|42006384|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.7|0.6
0-19|2.9|3.2|3.0|Malignant|1269|42006384|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|253|42158997|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.0|3.4|3.2|Malignant|1340|42158997|Male|Tumors of Neuroepthelial Tissue|2006|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|258|42367071|Male|Tumors of Neuroepthelial Tissue|2007|0.5|0.7|0.6
0-19|3.0|3.4|3.2|Malignant|1353|42367071|Male|Tumors of Neuroepthelial Tissue|2007|3.0|3.4|3.2
0-19|0.6|0.6|0.6|Benign/Borderline|1298|210572387|Male|Tumors of Neuroepthelial Tissue|2007-2011|0.6|0.7|0.6
0-19|3.2|3.3|3.3|Malignant|6845|210572387|Male|Tumors of Neuroepthelial Tissue|2007-2011|3.2|3.3|3.3
0-19|0.5|0.7|0.6|Benign/Borderline|259|42541971|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.7|0.6
0-19|3.1|3.5|3.3|Malignant|1403|42541971|Male|Tumors of Neuroepthelial Tissue|2008|3.1|3.5|3.3
0-19|0.5|0.7|0.6|Benign/Borderline|262|42609915|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1374|42609915|Male|Tumors of Neuroepthelial Tissue|2009|3.1|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|262|42550805|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.7|0.6
0-19|3.1|3.5|3.3|Malignant|1388|42550805|Male|Tumors of Neuroepthelial Tissue|2010|3.1|3.4|3.3
0-19|0.5|0.7|0.6|Benign/Borderline|261|42001185|Male|Tumors of Neuroepthelial Tissue|2011|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1355|42001185|Male|Tumors of Neuroepthelial Tissue|2011|3.1|3.4|3.2
0-19|0.3|0.5|0.4|Benign/Borderline|164|41889233|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|201|42006384|Male|Tumors of Sellar Region|2005|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|162|42158997|Male|Tumors of Sellar Region|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|199|42367071|Male|Tumors of Sellar Region|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|1013|210572387|Male|Tumors of Sellar Region|2007-2011|0.5|0.5|0.5
0-19|~|~|~|Malignant|~|210572387|Male|Tumors of Sellar Region|2007-2011|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|211|42541971|Male|Tumors of Sellar Region|2008|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|219|42609915|Male|Tumors of Sellar Region|2009|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|197|42550805|Male|Tumors of Sellar Region|2010|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42550805|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|188|42001185|Male|Tumors of Sellar Region|2011|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42001185|Male|Tumors of Sellar Region|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|41889233|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42006384|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|81|42158997|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|42367071|Male|Tumors of the Meninges|2007|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|441|210572387|Male|Tumors of the Meninges|2007-2011|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|42|210572387|Male|Tumors of the Meninges|2007-2011|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|82|42541971|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|42609915|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|85|42550805|Male|Tumors of the Meninges|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42550805|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|107|42001185|Male|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42001185|Male|Tumors of the Meninges|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|41889233|Male|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unclassified Tumors|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|42006384|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|18|42006384|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|80|42158997|Male|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|26|42158997|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|105|42367071|Male|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|27|42367071|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|560|210572387|Male|Unclassified Tumors|2007-2011|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|111|210572387|Male|Unclassified Tumors|2007-2011|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|76|42541971|Male|Unclassified Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Unclassified Tumors|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|139|42609915|Male|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|123|42550805|Male|Unclassified Tumors|2010|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|20|42550805|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|117|42001185|Male|Unclassified Tumors|2011|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|17|42001185|Male|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|30|41889233|Male|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42006384|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|28|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|142|210572387|Male|Unique astrocytoma variants|2007-2011|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|101|210572387|Male|Unique astrocytoma variants|2007-2011|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|33|42541971|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|42541971|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|35|42609915|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|42550805|Male|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42550805|Male|Unique astrocytoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|42001185|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|42001185|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|31|411503198|Male and Female|All other|2007-2011|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|42|411503198|Male and Female|All other|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|83180982|Male and Female|All other|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|82095288|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|68|81754354|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|66|82324418|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|83|82749431|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Anaplastic astrocytoma|2007-2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|378|411503198|Male and Female|Anaplastic astrocytoma|2007-2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|74|83118264|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|71|83280391|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|81|83180982|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|71|82095288|Male and Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82324418|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Anaplastic oligodendroglioma|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|32|411503198|Male and Female|Anaplastic oligodendroglioma|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|83180982|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|82095288|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|197|81754354|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|189|82005260|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|192|82324418|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82749431|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Astrocytoma, NOS|2007-2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|945|411503198|Male and Female|Astrocytoma, NOS|2007-2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|181|83118264|Male and Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|196|83280391|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|211|83180982|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|178|82095288|Male and Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|55|81754354|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|53|82005260|Male and Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|25|82005260|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82324418|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|63|82749431|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|319|411503198|Male and Female|Choroid plexus|2007-2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|92|411503198|Male and Female|Choroid plexus|2007-2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|77|83118264|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83118264|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|59|83280391|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|66|83180982|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|83180982|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|56|82095288|Male and Female|Choroid plexus|2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|19|82095288|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|162|81754354|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|163|82005260|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|151|82324418|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|179|82749431|Male and Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|811|411503198|Male and Female|Craniopharyngioma|2007-2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|411503198|Male and Female|Craniopharyngioma|2007-2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|152|83118264|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|169|83280391|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|168|83180982|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83180982|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|145|82095288|Male and Female|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82095288|Male and Female|Craniopharyngioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|82324418|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|40|82749431|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Diffuse astrocytoma|2007-2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|180|411503198|Male and Female|Diffuse astrocytoma|2007-2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|83118264|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|37|83280391|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|30|83180982|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82095288|Male and Female|Diffuse astrocytoma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|508|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|459|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|495|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|516|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Embryonal/primitive/medulloblastoma|2007-2011|~|~|~
0-19|0.6|0.6|0.6|Malignant|2526|411503198|Male and Female|Embryonal/primitive/medulloblastoma|2007-2011|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|549|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|504|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|488|83180982|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.5|0.6|0.6|Malignant|484|82095288|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82005260|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82324418|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|31|82749431|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|167|411503198|Male and Female|Ependymoma variants|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|411503198|Male and Female|Ependymoma variants|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83180982|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83180982|Male and Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82095288|Male and Female|Ependymoma variants|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82095288|Male and Female|Ependymoma variants|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|197|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|214|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|208|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|184|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Ependymoma/anaplastic ependymoma|2007-2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|958|411503198|Male and Female|Ependymoma/anaplastic ependymoma|2007-2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|172|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|196|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|208|83180982|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|206|82095288|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|30|81754354|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|147|81754354|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|34|82005260|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|132|82005260|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|41|82324418|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|125|82324418|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|31|82749431|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|132|82749431|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|179|411503198|Male and Female|Germ Cell Tumors|2007-2011|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|706|411503198|Male and Female|Germ Cell Tumors|2007-2011|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|35|83118264|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|142|83118264|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|45|83280391|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|137|83280391|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|38|83180982|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|162|83180982|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|31|82095288|Male and Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|134|82095288|Male and Female|Germ Cell Tumors|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|126|81754354|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|99|82005260|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|109|82324418|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|82749431|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Glioblastoma|2007-2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|644|411503198|Male and Female|Glioblastoma|2007-2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|127|83118264|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|120|83280391|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|118|83180982|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|153|82095288|Male and Female|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|458|81754354|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|441|82005260|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.6|0.6|Malignant|476|82324418|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|500|82749431|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|83|411503198|Male and Female|Glioma malignant, NOS|2007-2011|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|2585|411503198|Male and Female|Glioma malignant, NOS|2007-2011|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|522|83118264|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.7|Malignant|547|83280391|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|22|83180982|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.5|0.7|0.6|Malignant|493|83180982|Male and Female|Glioma malignant, NOS|2010|0.5|0.6|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|29|82095288|Male and Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|526|82095288|Male and Female|Glioma malignant, NOS|2011|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|28|81754354|Male and Female|Hemangioblastoma|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|82005260|Male and Female|Hemangioblastoma|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|23|82324418|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82749431|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|140|411503198|Male and Female|Hemangioblastoma|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|411503198|Male and Female|Hemangioblastoma|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|21|83118264|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|26|83280391|Male and Female|Hemangioblastoma|2009|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|83180982|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83180982|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82095288|Male and Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82095288|Male and Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|81754354|Male and Female|Hemangioma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|41|82005260|Male and Female|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|56|82324418|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|66|82749431|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|437|411503198|Male and Female|Hemangioma|2007-2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|411503198|Male and Female|Hemangioma|2007-2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|70|83118264|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|98|83280391|Male and Female|Hemangioma|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|89|83180982|Male and Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83180982|Male and Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|114|82095288|Male and Female|Hemangioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82095288|Male and Female|Hemangioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Local Extensions from Regional Tumors|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|411503198|Male and Female|Local Extensions from Regional Tumors|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|83180982|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|82095288|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|61|411503198|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|83180982|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|82095288|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|88|81754354|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|121|82005260|Male and Female|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|94|82324418|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|102|82749431|Male and Female|Meningioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|556|411503198|Male and Female|Meningioma|2007-2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|30|411503198|Male and Female|Meningioma|2007-2011|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|112|83118264|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|83280391|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|107|83180982|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83180982|Male and Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|121|82095288|Male and Female|Meningioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82095288|Male and Female|Meningioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|81754354|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|82005260|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|82324418|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82749431|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Mixed glioma|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|147|411503198|Male and Female|Mixed glioma|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|83118264|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|83280391|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|83180982|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Mixed glioma|2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|82095288|Male and Female|Mixed glioma|2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|58|81754354|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|41|81754354|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|104|82005260|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|36|82005260|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|97|82324418|Male and Female|Neoplasm, unspecified|2006|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|50|82324418|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|108|82749431|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|39|82749431|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|645|411503198|Male and Female|Neoplasm, unspecified|2007-2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|183|411503198|Male and Female|Neoplasm, unspecified|2007-2011|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|116|83118264|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|36|83118264|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|143|83280391|Male and Female|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|43|83280391|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|156|83180982|Male and Female|Neoplasm, unspecified|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|29|83180982|Male and Female|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|123|82095288|Male and Female|Neoplasm, unspecified|2011|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|37|82095288|Male and Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|217|81754354|Male and Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|255|82005260|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|290|82324418|Male and Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|254|82749431|Male and Female|Nerve sheath, benign and malignant|2007|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1186|411503198|Male and Female|Nerve sheath, benign and malignant|2007-2011|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|20|411503198|Male and Female|Nerve sheath, benign and malignant|2007-2011|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|245|83118264|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|259|83280391|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|213|83180982|Male and Female|Nerve sheath, benign and malignant|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|83180982|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|216|82095288|Male and Female|Nerve sheath, benign and malignant|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82095288|Male and Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Neuroepithelial|2007-2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|37|411503198|Male and Female|Neuroepithelial|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|83180982|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|82095288|Male and Female|Neuroepithelial|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|259|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|50|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|292|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|272|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|53|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|301|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|60|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|1488|411503198|Male and Female|Neuronal/glial, neuronal|2007-2011|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|210|411503198|Male and Female|Neuronal/glial, neuronal|2007-2011|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|294|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|54|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|288|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|29|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|301|83180982|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|34|83180982|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|307|82095288|Male and Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|33|82095288|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|63|81754354|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|51|82005260|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|50|82749431|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Oligodendroglioma|2007-2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|217|411503198|Male and Female|Oligodendroglioma|2007-2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|47|83118264|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|42|83280391|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83180982|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82095288|Male and Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|26|81754354|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|82005260|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82324418|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|26|82749431|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|194|411503198|Male and Female|Other mesenchymal|2007-2011|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Malignant|58|411503198|Male and Female|Other mesenchymal|2007-2011|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|34|83118264|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|44|83280391|Male and Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|83180982|Male and Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83180982|Male and Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|47|82095288|Male and Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82095288|Male and Female|Other mesenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.8|Malignant|688|81754354|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|657|82005260|Male and Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|666|82324418|Male and Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|668|82749431|Male and Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|411503198|Male and Female|Pilocytic astrocytoma|2007-2011|~|~|~
0-19|0.8|0.9|0.8|Malignant|3464|411503198|Male and Female|Pilocytic astrocytoma|2007-2011|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|0.9|0.9|Malignant|704|83118264|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.8|Malignant|689|83280391|Male and Female|Pilocytic astrocytoma|2009|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|0.9|0.9|Malignant|725|83180982|Male and Female|Pilocytic astrocytoma|2010|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|0.9|0.9|Malignant|697|82095288|Male and Female|Pilocytic astrocytoma|2011|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|82005260|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|82324418|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|39|411503198|Male and Female|Pineal parenchymal|2007-2011|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|148|411503198|Male and Female|Pineal parenchymal|2007-2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83180982|Male and Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|83180982|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82095288|Male and Female|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82095288|Male and Female|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|321|81754354|Male and Female|Pituitary|2004|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|390|82005260|Male and Female|Pituitary|2005|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|391|82324418|Male and Female|Pituitary|2006|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|412|82749431|Male and Female|Pituitary|2007|0.5|0.5|0.5
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|2261|411503198|Male and Female|Pituitary|2007-2011|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|411503198|Male and Female|Pituitary|2007-2011|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|449|83118264|Male and Female|Pituitary|2008|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|467|83280391|Male and Female|Pituitary|2009|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|492|83180982|Male and Female|Pituitary|2010|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|83180982|Male and Female|Pituitary|2010|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|447|82095288|Male and Female|Pituitary|2011|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82095288|Male and Female|Pituitary|2011|~|~|~
0-19|1.6|1.8|1.7|Benign/Borderline|1376|81754354|Male and Female|Total|2004|1.6|1.8|1.7
0-19|3.3|3.5|3.4|Malignant|2777|81754354|Male and Female|Total|2004|3.3|3.5|3.4
0-19|1.9|2.0|1.9|Benign/Borderline|1616|82005260|Male and Female|Total|2005|1.9|2.1|2.0
0-19|3.1|3.3|3.2|Malignant|2615|82005260|Male and Female|Total|2005|3.1|3.3|3.2
0-19|1.9|2.0|1.9|Benign/Borderline|1624|82324418|Male and Female|Total|2006|1.9|2.1|2.0
0-19|3.2|3.4|3.3|Malignant|2698|82324418|Male and Female|Total|2006|3.2|3.4|3.3
0-19|1.9|2.1|2.0|Benign/Borderline|1694|82749431|Male and Female|Total|2007|2.0|2.1|2.0
0-19|3.2|3.5|3.4|Malignant|2780|82749431|Male and Female|Total|2007|3.2|3.5|3.4
0-19|2.1|2.2|2.1|Benign/Borderline|8779|411503198|Male and Female|Total|2007-2011|2.1|2.2|2.1
0-19|3.3|3.4|3.4|Malignant|13863|411503198|Male and Female|Total|2007-2011|3.3|3.4|3.4
0-19|1.9|2.1|2.0|Benign/Borderline|1709|83118264|Male and Female|Total|2008|2.0|2.2|2.1
0-19|3.3|3.5|3.4|Malignant|2824|83118264|Male and Female|Total|2008|3.3|3.5|3.4
0-19|2.1|2.3|2.2|Benign/Borderline|1825|83280391|Male and Female|Total|2009|2.1|2.3|2.2
0-19|3.2|3.5|3.3|Malignant|2772|83280391|Male and Female|Total|2009|3.2|3.5|3.3
0-19|2.1|2.3|2.2|Benign/Borderline|1810|83180982|Male and Female|Total|2010|2.1|2.3|2.2
0-19|3.2|3.5|3.4|Malignant|2790|83180982|Male and Female|Total|2010|3.2|3.5|3.4
0-19|2.0|2.2|2.1|Benign/Borderline|1759|82095288|Male and Female|Total|2011|2.0|2.2|2.1
0-19|3.2|3.5|3.4|Malignant|2761|82095288|Male and Female|Total|2011|3.2|3.5|3.4
0-19|0.2|0.3|0.3|Benign/Borderline|217|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|255|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|290|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|254|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1187|411503198|Male and Female|Tumors of Cranial and Spinal Nerves|2007-2011|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|20|411503198|Male and Female|Tumors of Cranial and Spinal Nerves|2007-2011|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|245|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|259|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|213|83180982|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|83180982|Male and Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|217|82095288|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82095288|Male and Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.5|0.5|0.5|Benign/Borderline|407|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.5|0.5|0.5
0-19|3.0|3.2|3.1|Malignant|2541|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.2|3.1
0-19|0.5|0.6|0.5|Benign/Borderline|443|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.5
0-19|2.8|3.1|2.9|Malignant|2393|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.8|3.0|2.9
0-19|0.5|0.6|0.5|Benign/Borderline|448|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
0-19|2.9|3.2|3.0|Malignant|2481|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|480|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2568|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|3.0|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|2365|411503198|Male and Female|Tumors of Neuroepthelial Tissue|2007-2011|0.6|0.6|0.6
0-19|3.1|3.2|3.1|Malignant|12765|411503198|Male and Female|Tumors of Neuroepthelial Tissue|2007-2011|3.0|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|472|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.6
0-19|3.0|3.3|3.1|Malignant|2607|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|3.0|3.3|3.1
0-19|0.5|0.6|0.5|Benign/Borderline|459|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2545|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|2.9|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|479|83180982|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2553|83180982|Male and Female|Tumors of Neuroepthelial Tissue|2010|3.0|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|481|82095288|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2552|82095288|Male and Female|Tumors of Neuroepthelial Tissue|2011|3.0|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|483|81754354|Male and Female|Tumors of Sellar Region|2004|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|553|82005260|Male and Female|Tumors of Sellar Region|2005|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|542|82324418|Male and Female|Tumors of Sellar Region|2006|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|591|82749431|Male and Female|Tumors of Sellar Region|2007|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|3072|411503198|Male and Female|Tumors of Sellar Region|2007-2011|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|411503198|Male and Female|Tumors of Sellar Region|2007-2011|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|601|83118264|Male and Female|Tumors of Sellar Region|2008|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|636|83280391|Male and Female|Tumors of Sellar Region|2009|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|660|83180982|Male and Female|Tumors of Sellar Region|2010|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|83180982|Male and Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|592|82095288|Male and Female|Tumors of Sellar Region|2011|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82095288|Male and Female|Tumors of Sellar Region|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|142|81754354|Male and Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|19|81754354|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|186|82005260|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|82005260|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|150|82324418|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|16|82324418|Male and Female|Tumors of the Meninges|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|164|82749431|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82749431|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|890|411503198|Male and Female|Tumors of the Meninges|2007-2011|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|89|411503198|Male and Female|Tumors of the Meninges|2007-2011|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|167|83118264|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|185|83280391|Male and Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|23|83280391|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|174|83180982|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|83180982|Male and Female|Tumors of the Meninges|2010|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|201|82095288|Male and Female|Tumors of the Meninges|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82095288|Male and Female|Tumors of the Meninges|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|96|81754354|Male and Female|Unclassified Tumors|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|41|81754354|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|145|82005260|Male and Female|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|37|82005260|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|153|82324418|Male and Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|174|82749431|Male and Female|Unclassified Tumors|2007|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|44|82749431|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|1083|411503198|Male and Female|Unclassified Tumors|2007-2011|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|197|411503198|Male and Female|Unclassified Tumors|2007-2011|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|186|83118264|Male and Female|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|39|83118264|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|241|83280391|Male and Female|Unclassified Tumors|2009|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|45|83280391|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|246|83180982|Male and Female|Unclassified Tumors|2010|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|32|83180982|Male and Female|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|237|82095288|Male and Female|Unclassified Tumors|2011|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|38|82095288|Male and Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|47|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|54|82005260|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|28|82005260|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|47|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|62|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|55|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|256|411503198|Male and Female|Unique astrocytoma variants|2007-2011|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|197|411503198|Male and Female|Unique astrocytoma variants|2007-2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|53|83118264|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|30|83118264|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|63|83280391|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|42|83280391|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|40|83180982|Male and Female|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Malignant|25|83180982|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|39|82095288|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|46|82095288|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|109112165|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110320645|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|111567226|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|112783993|Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|78|571759383|Female|All other|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|571759383|Female|All other|2007-2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|114027722|Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|17|115293599|Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|17|116607751|Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|116607751|Female|All other|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116884558|Female|All other|2011|~|~|~
20+|~|~|~|Malignant|~|116884558|Female|All other|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|565|109112165|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|512|110320645|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|506|111567226|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|530|112783993|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|571759383|Female|Anaplastic astrocytoma|2007-2011|~|~|~
20+|0.4|0.5|0.4|Malignant|2617|571759383|Female|Anaplastic astrocytoma|2007-2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|495|114027722|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|495|115293599|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116607751|Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|557|116607751|Female|Anaplastic astrocytoma|2010|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|116884558|Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|553|116884558|Female|Anaplastic astrocytoma|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|181|109112165|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|165|110320645|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|136|111567226|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|151|112783993|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|571759383|Female|Anaplastic oligodendroglioma|2007-2011|~|~|~
20+|0.1|0.1|0.1|Malignant|724|571759383|Female|Anaplastic oligodendroglioma|2007-2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|165|114027722|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|141|115293599|Female|Anaplastic oligodendroglioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116607751|Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|128|116607751|Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116884558|Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|142|116884558|Female|Anaplastic oligodendroglioma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|570|109112165|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.5|0.5|Malignant|555|110320645|Female|Astrocytoma, NOS|2005|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|535|111567226|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|526|112783993|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|571759383|Female|Astrocytoma, NOS|2007-2011|~|~|~
20+|0.4|0.4|0.4|Malignant|2370|571759383|Female|Astrocytoma, NOS|2007-2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|483|114027722|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|479|115293599|Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116607751|Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|461|116607751|Female|Astrocytoma, NOS|2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|116884558|Female|Astrocytoma, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|432|116884558|Female|Astrocytoma, NOS|2011|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|38|109112165|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|110320645|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|41|111567226|Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|54|112783993|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|238|571759383|Female|Choroid plexus|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|571759383|Female|Choroid plexus|2007-2011|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|46|114027722|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|44|115293599|Female|Choroid plexus|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|47|116607751|Female|Choroid plexus|2010|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116607751|Female|Choroid plexus|2010|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|47|116884558|Female|Choroid plexus|2011|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116884558|Female|Choroid plexus|2011|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|192|109112165|Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|180|110320645|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|196|111567226|Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|215|112783993|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1078|571759383|Female|Craniopharyngioma|2007-2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|571759383|Female|Craniopharyngioma|2007-2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|217|114027722|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|219|115293599|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|226|116607751|Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116607751|Female|Craniopharyngioma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|205|116884558|Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116884558|Female|Craniopharyngioma|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|113|109112165|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|130|110320645|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|93|111567226|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|132|112783993|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|571759383|Female|Diffuse astrocytoma|2007-2011|~|~|~
20+|0.1|0.1|0.1|Malignant|699|571759383|Female|Diffuse astrocytoma|2007-2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|136|114027722|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|160|115293599|Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116607751|Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|161|116607751|Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116884558|Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|111|116884558|Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|84|110320645|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|73|111567226|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|90|112783993|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|571759383|Female|Embryonal/primitive/medulloblastoma|2007-2011|~|~|~
20+|0.1|0.1|0.1|Malignant|417|571759383|Female|Embryonal/primitive/medulloblastoma|2007-2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|87|114027722|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|104|115293599|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116607751|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|73|116607751|Female|Embryonal/primitive/medulloblastoma|2010|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116884558|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.0|0.1|0.1|Malignant|66|116884558|Female|Embryonal/primitive/medulloblastoma|2011|0.0|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|105|109112165|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|119|110320645|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|111567226|Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|112783993|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|558|571759383|Female|Ependymoma variants|2007-2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|571759383|Female|Ependymoma variants|2007-2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|107|114027722|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|112|115293599|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|117|116607751|Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116607751|Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|112|116884558|Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116884558|Female|Ependymoma variants|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|292|109112165|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|299|110320645|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|292|111567226|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|291|112783993|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|31|571759383|Female|Ependymoma/anaplastic ependymoma|2007-2011|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|1497|571759383|Female|Ependymoma/anaplastic ependymoma|2007-2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|309|114027722|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|335|115293599|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116607751|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|290|116607751|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116884558|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.2|Malignant|283|116884558|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|110320645|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|111567226|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|112783993|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|162|571759383|Female|Germ Cell Tumors|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|571759383|Female|Germ Cell Tumors|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|114027722|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|115293599|Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|116607751|Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116607751|Female|Germ Cell Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|116884558|Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116884558|Female|Germ Cell Tumors|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|4084|109112165|Female|Glioblastoma|2004|3.6|3.9|3.7
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4146|110320645|Female|Glioblastoma|2005|3.6|3.9|3.8
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006|~|~|~
20+|3.4|3.7|3.5|Malignant|4279|111567226|Female|Glioblastoma|2006|3.7|4.0|3.8
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007|~|~|~
20+|3.4|3.7|3.6|Malignant|4362|112783993|Female|Glioblastoma|2007|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|571759383|Female|Glioblastoma|2007-2011|~|~|~
20+|3.4|3.5|3.5|Malignant|22164|571759383|Female|Glioblastoma|2007-2011|3.8|3.9|3.9
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4397|114027722|Female|Glioblastoma|2008|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009|~|~|~
20+|3.4|3.6|3.5|Malignant|4440|115293599|Female|Glioblastoma|2009|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|116607751|Female|Glioblastoma|2010|~|~|~
20+|3.4|3.6|3.5|Malignant|4570|116607751|Female|Glioblastoma|2010|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|116884558|Female|Glioblastoma|2011|~|~|~
20+|3.3|3.5|3.4|Malignant|4505|116884558|Female|Glioblastoma|2011|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|419|109112165|Female|Glioma malignant, NOS|2004|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|386|110320645|Female|Glioma malignant, NOS|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|390|111567226|Female|Glioma malignant, NOS|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|404|112783993|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|39|571759383|Female|Glioma malignant, NOS|2007-2011|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|2106|571759383|Female|Glioma malignant, NOS|2007-2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|430|114027722|Female|Glioma malignant, NOS|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|498|115293599|Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116607751|Female|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|385|116607751|Female|Glioma malignant, NOS|2010|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|116884558|Female|Glioma malignant, NOS|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|401|116884558|Female|Glioma malignant, NOS|2011|0.3|0.4|0.3
20+|0.2|0.2|0.2|Benign/Borderline|202|109112165|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|110320645|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|214|111567226|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|206|112783993|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1101|571759383|Female|Hemangioblastoma|2007-2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|571759383|Female|Hemangioblastoma|2007-2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|233|114027722|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|224|115293599|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|216|116607751|Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116607751|Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|116884558|Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116884558|Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|109112165|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|267|110320645|Female|Hemangioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|299|111567226|Female|Hemangioma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|345|112783993|Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|2476|571759383|Female|Hemangioma|2007-2011|0.4|0.5|0.4
20+|~|~|~|Malignant|~|571759383|Female|Hemangioma|2007-2011|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|427|114027722|Female|Hemangioma|2008|0.3|0.4|0.4
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|475|115293599|Female|Hemangioma|2009|0.4|0.5|0.4
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|593|116607751|Female|Hemangioma|2010|0.5|0.6|0.5
20+|~|~|~|Malignant|~|116607751|Female|Hemangioma|2010|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|640|116884558|Female|Hemangioma|2011|0.5|0.6|0.5
20+|~|~|~|Malignant|~|116884558|Female|Hemangioma|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|17|111567226|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112783993|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|571759383|Female|Local Extensions from Regional Tumors|2007-2011|~|~|~
20+|0.0|0.0|0.0|Malignant|111|571759383|Female|Local Extensions from Regional Tumors|2007-2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|115293599|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116607751|Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|21|116607751|Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116884558|Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|21|116884558|Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|593|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|659|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|671|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|631|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|571759383|Female|Lymphomas and Hematopoietic Neoplasms|2007-2011|~|~|~
20+|0.5|0.6|0.5|Malignant|3408|571759383|Female|Lymphomas and Hematopoietic Neoplasms|2007-2011|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|696|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|658|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|116607751|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|745|116607751|Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|116884558|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|699|116884558|Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.6|0.6
20+|11.5|11.9|11.7|Benign/Borderline|13570|109112165|Female|Meningioma|2004|12.2|12.6|12.4
20+|0.2|0.3|0.2|Malignant|275|109112165|Female|Meningioma|2004|0.2|0.3|0.3
20+|12.9|13.3|13.1|Benign/Borderline|15491|110320645|Female|Meningioma|2005|13.8|14.3|14.0
20+|0.2|0.3|0.2|Malignant|277|110320645|Female|Meningioma|2005|0.2|0.3|0.3
20+|13.4|13.8|13.6|Benign/Borderline|16393|111567226|Female|Meningioma|2006|14.5|14.9|14.7
20+|0.2|0.2|0.2|Malignant|252|111567226|Female|Meningioma|2006|0.2|0.3|0.2
20+|13.7|14.2|13.9|Benign/Borderline|17065|112783993|Female|Meningioma|2007|14.9|15.4|15.1
20+|0.2|0.2|0.2|Malignant|268|112783993|Female|Meningioma|2007|0.2|0.3|0.2
20+|14.3|14.5|14.4|Benign/Borderline|90465|571759383|Female|Meningioma|2007-2011|15.7|15.9|15.8
20+|0.2|0.2|0.2|Malignant|1033|571759383|Female|Meningioma|2007-2011|0.2|0.2|0.2
20+|14.3|14.7|14.5|Benign/Borderline|18043|114027722|Female|Meningioma|2008|15.6|16.1|15.8
20+|0.1|0.2|0.2|Malignant|210|114027722|Female|Meningioma|2008|0.2|0.2|0.2
20+|15.0|15.4|15.2|Benign/Borderline|19267|115293599|Female|Meningioma|2009|16.5|16.9|16.7
20+|0.1|0.2|0.2|Malignant|199|115293599|Female|Meningioma|2009|0.1|0.2|0.2
20+|14.1|14.5|14.3|Benign/Borderline|18405|116607751|Female|Meningioma|2010|15.6|16.0|15.8
20+|0.1|0.2|0.1|Malignant|190|116607751|Female|Meningioma|2010|0.1|0.2|0.2
20+|13.8|14.2|14.0|Benign/Borderline|18149|116884558|Female|Meningioma|2011|15.3|15.8|15.5
20+|0.1|0.2|0.1|Malignant|171|116884558|Female|Meningioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|195|109112165|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|235|110320645|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|267|111567226|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|236|112783993|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|571759383|Female|Mixed glioma|2007-2011|~|~|~
20+|0.2|0.2|0.2|Malignant|1290|571759383|Female|Mixed glioma|2007-2011|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|258|114027722|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.2|Malignant|277|115293599|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116607751|Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|262|116607751|Female|Mixed glioma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116884558|Female|Mixed glioma|2011|~|~|~
20+|0.2|0.3|0.2|Malignant|264|116884558|Female|Mixed glioma|2011|0.2|0.3|0.2
20+|0.5|0.6|0.6|Benign/Borderline|676|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|703|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Benign/Borderline|856|110320645|Female|Neoplasm, unspecified|2005|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|728|110320645|Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|775|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.5|0.6|0.6|Malignant|724|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|807|112783993|Female|Neoplasm, unspecified|2007|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|653|112783993|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|3961|571759383|Female|Neoplasm, unspecified|2007-2011|0.7|0.7|0.7
20+|0.5|0.5|0.5|Malignant|3412|571759383|Female|Neoplasm, unspecified|2007-2011|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|801|114027722|Female|Neoplasm, unspecified|2008|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|755|114027722|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|872|115293599|Female|Neoplasm, unspecified|2009|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|779|115293599|Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.5|0.6|0.6|Benign/Borderline|752|116607751|Female|Neoplasm, unspecified|2010|0.6|0.7|0.6
20+|0.4|0.5|0.5|Malignant|641|116607751|Female|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|748|116884558|Female|Neoplasm, unspecified|2011|0.6|0.7|0.6
20+|0.4|0.5|0.4|Malignant|612|116884558|Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|2.1|2.3|2.2|Benign/Borderline|2458|109112165|Female|Nerve sheath, benign and malignant|2004|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|20|109112165|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2706|110320645|Female|Nerve sheath, benign and malignant|2005|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2823|111567226|Female|Nerve sheath, benign and malignant|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2782|112783993|Female|Nerve sheath, benign and malignant|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|13935|571759383|Female|Nerve sheath, benign and malignant|2007-2011|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|121|571759383|Female|Nerve sheath, benign and malignant|2007-2011|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2853|114027722|Female|Nerve sheath, benign and malignant|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|114027722|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2949|115293599|Female|Nerve sheath, benign and malignant|2009|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|2669|116607751|Female|Nerve sheath, benign and malignant|2010|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|22|116607751|Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|2732|116884558|Female|Nerve sheath, benign and malignant|2011|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|19|116884558|Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|16|111567226|Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|571759383|Female|Neuroepithelial|2007-2011|~|~|~
20+|0.0|0.0|0.0|Malignant|112|571759383|Female|Neuroepithelial|2007-2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116607751|Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|116607751|Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116884558|Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|19|116884558|Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|152|109112165|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|182|110320645|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|110320645|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|182|111567226|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|111567226|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|198|112783993|Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|112783993|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1072|571759383|Female|Neuronal/glial, neuronal|2007-2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|101|571759383|Female|Neuronal/glial, neuronal|2007-2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|201|114027722|Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|114027722|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|214|115293599|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|115293599|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|237|116607751|Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|116607751|Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|226|116884558|Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|116884558|Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|347|109112165|Female|Oligodendroglioma|2004|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|349|110320645|Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|371|111567226|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|361|112783993|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|571759383|Female|Oligodendroglioma|2007-2011|~|~|~
20+|0.3|0.3|0.3|Malignant|1664|571759383|Female|Oligodendroglioma|2007-2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|349|114027722|Female|Oligodendroglioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|346|115293599|Female|Oligodendroglioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116607751|Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|322|116607751|Female|Oligodendroglioma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116884558|Female|Oligodendroglioma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|295|116884558|Female|Oligodendroglioma|2011|0.2|0.3|0.3
20+|0.0|0.1|0.1|Benign/Borderline|66|109112165|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|80|110320645|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|110320645|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|111567226|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|111567226|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|112783993|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|112783993|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|442|571759383|Female|Other mesenchymal|2007-2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|174|571759383|Female|Other mesenchymal|2007-2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|102|114027722|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|50|114027722|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|90|115293599|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|115293599|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|92|116607751|Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|33|116607751|Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|78|116884558|Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|116884558|Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|122|109112165|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|148|110320645|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|149|111567226|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|159|112783993|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|571759383|Female|Pilocytic astrocytoma|2007-2011|~|~|~
20+|0.1|0.1|0.1|Malignant|742|571759383|Female|Pilocytic astrocytoma|2007-2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|144|114027722|Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|130|115293599|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116607751|Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|161|116607751|Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116884558|Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|154|116884558|Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|110320645|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|178|571759383|Female|Pineal parenchymal|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|120|571759383|Female|Pineal parenchymal|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|41|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|39|116607751|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|116607751|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|39|116884558|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|116884558|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|3.4|3.6|3.5|Benign/Borderline|3782|109112165|Female|Pituitary|2004|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Pituitary|2004|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|4367|110320645|Female|Pituitary|2005|3.8|4.1|4.0
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.2|4.5|4.4|Benign/Borderline|4840|111567226|Female|Pituitary|2006|4.2|4.5|4.3
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006|~|~|~
20+|4.3|4.5|4.4|Benign/Borderline|4901|112783993|Female|Pituitary|2007|4.2|4.5|4.3
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007|~|~|~
20+|4.6|4.8|4.7|Benign/Borderline|26597|571759383|Female|Pituitary|2007-2011|4.6|4.7|4.7
20+|0.0|0.0|0.0|Malignant|52|571759383|Female|Pituitary|2007-2011|0.0|0.0|0.0
20+|4.5|4.7|4.6|Benign/Borderline|5215|114027722|Female|Pituitary|2008|4.5|4.7|4.6
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008|~|~|~
20+|4.9|5.2|5.0|Benign/Borderline|5741|115293599|Female|Pituitary|2009|4.9|5.1|5.0
20+|~|~|~|Malignant|~|115293599|Female|Pituitary|2009|~|~|~
20+|4.6|4.9|4.7|Benign/Borderline|5474|116607751|Female|Pituitary|2010|4.6|4.8|4.7
20+|~|~|~|Malignant|~|116607751|Female|Pituitary|2010|~|~|~
20+|4.5|4.8|4.6|Benign/Borderline|5358|116884558|Female|Pituitary|2011|4.5|4.7|4.6
20+|~|~|~|Malignant|~|116884558|Female|Pituitary|2011|~|~|~
20+|18.6|19.1|18.9|Benign/Borderline|21563|109112165|Female|Total|2004|19.5|20.0|19.8
20+|7.4|7.8|7.6|Malignant|8710|109112165|Female|Total|2004|7.8|8.2|8.0
20+|21.0|21.5|21.3|Benign/Borderline|24642|110320645|Female|Total|2005|22.1|22.6|22.3
20+|7.5|7.8|7.6|Malignant|8868|110320645|Female|Total|2005|7.9|8.2|8.0
20+|22.0|22.5|22.2|Benign/Borderline|26131|111567226|Female|Total|2006|23.1|23.7|23.4
20+|7.4|7.7|7.6|Malignant|8928|111567226|Female|Total|2006|7.8|8.2|8.0
20+|22.3|22.8|22.5|Benign/Borderline|26911|112783993|Female|Total|2007|23.6|24.1|23.9
20+|7.4|7.7|7.5|Malignant|9000|112783993|Female|Total|2007|7.8|8.1|8.0
20+|23.3|23.5|23.4|Benign/Borderline|142709|571759383|Female|Total|2007-2011|24.8|25.1|25.0
20+|7.3|7.4|7.3|Malignant|45159|571759383|Female|Total|2007-2011|7.8|8.0|7.9
20+|23.1|23.7|23.4|Benign/Borderline|28403|114027722|Female|Total|2008|24.6|25.2|24.9
20+|7.3|7.7|7.5|Malignant|9145|114027722|Female|Total|2008|7.9|8.2|8.0
20+|24.4|25.0|24.7|Benign/Borderline|30377|115293599|Female|Total|2009|26.1|26.6|26.3
20+|7.3|7.6|7.4|Malignant|9243|115293599|Female|Total|2009|7.9|8.2|8.0
20+|23.0|23.5|23.2|Benign/Borderline|28977|116607751|Female|Total|2010|24.6|25.1|24.8
20+|7.1|7.4|7.2|Malignant|9142|116607751|Female|Total|2010|7.7|8.0|7.8
20+|22.7|23.2|22.9|Benign/Borderline|28689|116884558|Female|Total|2011|24.3|24.8|24.5
20+|6.8|7.1|7.0|Malignant|8872|116884558|Female|Total|2011|7.4|7.8|7.6
20+|2.1|2.3|2.2|Benign/Borderline|2458|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|20|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2709|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2824|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2783|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|13945|571759383|Female|Tumors of Cranial and Spinal Nerves|2007-2011|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|121|571759383|Female|Tumors of Cranial and Spinal Nerves|2007-2011|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2855|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2952|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|2671|116607751|Female|Tumors of Cranial and Spinal Nerves|2010|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|22|116607751|Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|2734|116884558|Female|Tumors of Cranial and Spinal Nerves|2011|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|19|116884558|Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|0.3|0.4|0.3|Benign/Borderline|373|109112165|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|6.0|6.3|6.2|Malignant|7027|109112165|Female|Tumors of Neuroepthelial Tissue|2004|6.3|6.6|6.4
20+|0.4|0.4|0.4|Benign/Borderline|433|110320645|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|6.0|6.3|6.1|Malignant|7093|110320645|Female|Tumors of Neuroepthelial Tissue|2005|6.3|6.6|6.4
20+|0.4|0.5|0.4|Benign/Borderline|466|111567226|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|6.0|6.3|6.1|Malignant|7179|111567226|Female|Tumors of Neuroepthelial Tissue|2006|6.3|6.6|6.4
20+|0.4|0.5|0.4|Benign/Borderline|468|112783993|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7332|112783993|Female|Tumors of Neuroepthelial Tissue|2007|6.4|6.7|6.5
20+|0.4|0.5|0.4|Benign/Borderline|2460|571759383|Female|Tumors of Neuroepthelial Tissue|2007-2011|0.4|0.4|0.4
20+|6.0|6.1|6.0|Malignant|36762|571759383|Female|Tumors of Neuroepthelial Tissue|2007-2011|6.4|6.5|6.4
20+|0.4|0.5|0.4|Benign/Borderline|472|114027722|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.4
20+|6.0|6.2|6.1|Malignant|7354|114027722|Female|Tumors of Neuroepthelial Tissue|2008|6.3|6.6|6.4
20+|0.4|0.5|0.4|Benign/Borderline|498|115293599|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|6.0|6.2|6.1|Malignant|7509|115293599|Female|Tumors of Neuroepthelial Tissue|2009|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|515|116607751|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.5|0.4
20+|5.8|6.1|6.0|Malignant|7460|116607751|Female|Tumors of Neuroepthelial Tissue|2010|6.3|6.5|6.4
20+|0.4|0.5|0.4|Benign/Borderline|516|116884558|Female|Tumors of Neuroepthelial Tissue|2011|0.4|0.5|0.4
20+|5.6|5.9|5.8|Malignant|7295|116884558|Female|Tumors of Neuroepthelial Tissue|2011|6.1|6.4|6.2
20+|3.5|3.8|3.6|Benign/Borderline|3974|109112165|Female|Tumors of Sellar Region|2004|3.5|3.8|3.6
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.0|4.3|4.1|Benign/Borderline|4547|110320645|Female|Tumors of Sellar Region|2005|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.4|4.7|4.5|Benign/Borderline|5036|111567226|Female|Tumors of Sellar Region|2006|4.4|4.6|4.5
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006|~|~|~
20+|4.4|4.7|4.6|Benign/Borderline|5116|112783993|Female|Tumors of Sellar Region|2007|4.4|4.7|4.5
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007|~|~|~
20+|4.8|4.9|4.9|Benign/Borderline|27675|571759383|Female|Tumors of Sellar Region|2007-2011|4.8|4.9|4.8
20+|0.0|0.0|0.0|Malignant|56|571759383|Female|Tumors of Sellar Region|2007-2011|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|5432|114027722|Female|Tumors of Sellar Region|2008|4.6|4.9|4.8
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008|~|~|~
20+|5.1|5.3|5.2|Benign/Borderline|5960|115293599|Female|Tumors of Sellar Region|2009|5.0|5.3|5.2
20+|~|~|~|Malignant|~|115293599|Female|Tumors of Sellar Region|2009|~|~|~
20+|4.8|5.1|4.9|Benign/Borderline|5700|116607751|Female|Tumors of Sellar Region|2010|4.8|5.0|4.9
20+|~|~|~|Malignant|~|116607751|Female|Tumors of Sellar Region|2010|~|~|~
20+|4.7|4.9|4.8|Benign/Borderline|5563|116884558|Female|Tumors of Sellar Region|2011|4.6|4.9|4.8
20+|~|~|~|Malignant|~|116884558|Female|Tumors of Sellar Region|2011|~|~|~
20+|11.7|12.1|11.9|Benign/Borderline|13838|109112165|Female|Tumors of the Meninges|2004|12.5|12.9|12.7
20+|0.2|0.3|0.3|Malignant|299|109112165|Female|Tumors of the Meninges|2004|0.2|0.3|0.3
20+|13.1|13.6|13.4|Benign/Borderline|15791|110320645|Female|Tumors of the Meninges|2005|14.1|14.5|14.3
20+|0.2|0.3|0.3|Malignant|304|110320645|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|13.7|14.1|13.9|Benign/Borderline|16690|111567226|Female|Tumors of the Meninges|2006|14.7|15.2|15.0
20+|0.2|0.3|0.2|Malignant|282|111567226|Female|Tumors of the Meninges|2006|0.2|0.3|0.3
20+|14.0|14.4|14.2|Benign/Borderline|17352|112783993|Female|Tumors of the Meninges|2007|15.2|15.6|15.4
20+|0.2|0.3|0.2|Malignant|304|112783993|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|14.6|14.8|14.7|Benign/Borderline|92008|571759383|Female|Tumors of the Meninges|2007-2011|16.0|16.2|16.1
20+|0.2|0.2|0.2|Malignant|1210|571759383|Female|Tumors of the Meninges|2007-2011|0.2|0.2|0.2
20+|14.6|15.0|14.8|Benign/Borderline|18378|114027722|Female|Tumors of the Meninges|2008|15.9|16.4|16.1
20+|0.2|0.2|0.2|Malignant|260|114027722|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
20+|15.3|15.7|15.5|Benign/Borderline|19581|115293599|Female|Tumors of the Meninges|2009|16.7|17.2|17.0
20+|0.2|0.2|0.2|Malignant|227|115293599|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|14.3|14.8|14.6|Benign/Borderline|18713|116607751|Female|Tumors of the Meninges|2010|15.8|16.3|16.0
20+|0.2|0.2|0.2|Malignant|223|116607751|Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|14.1|14.5|14.3|Benign/Borderline|18454|116884558|Female|Tumors of the Meninges|2011|15.6|16.0|15.8
20+|0.1|0.2|0.2|Malignant|201|116884558|Female|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|0.7|0.8|0.8|Benign/Borderline|902|109112165|Female|Unclassified Tumors|2004|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|709|109112165|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1126|110320645|Female|Unclassified Tumors|2005|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|734|110320645|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.9|1.0|0.9|Benign/Borderline|1082|111567226|Female|Unclassified Tumors|2006|0.9|1.0|1.0
20+|0.5|0.6|0.6|Malignant|729|111567226|Female|Unclassified Tumors|2006|0.6|0.7|0.7
20+|0.9|1.0|1.0|Benign/Borderline|1156|112783993|Female|Unclassified Tumors|2007|1.0|1.1|1.0
20+|0.5|0.5|0.5|Malignant|656|112783993|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|6454|571759383|Female|Unclassified Tumors|2007-2011|1.1|1.2|1.1
20+|0.5|0.5|0.5|Malignant|3451|571759383|Female|Unclassified Tumors|2007-2011|0.6|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1234|114027722|Female|Unclassified Tumors|2008|1.0|1.1|1.1
20+|0.5|0.6|0.6|Malignant|769|114027722|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.0|1.2|1.1|Benign/Borderline|1348|115293599|Female|Unclassified Tumors|2009|1.1|1.2|1.2
20+|0.5|0.6|0.6|Malignant|787|115293599|Female|Unclassified Tumors|2009|0.6|0.7|0.7
20+|1.0|1.1|1.1|Benign/Borderline|1348|116607751|Female|Unclassified Tumors|2010|1.1|1.2|1.2
20+|0.4|0.5|0.5|Malignant|649|116607751|Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|1391|116884558|Female|Unclassified Tumors|2011|1.1|1.3|1.2
20+|0.4|0.5|0.4|Malignant|618|116884558|Female|Unclassified Tumors|2011|0.5|0.6|0.5
20+|0.0|0.1|0.0|Benign/Borderline|52|109112165|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|41|110320645|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|21|110320645|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|46|111567226|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|24|111567226|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|60|112783993|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|112783993|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|315|571759383|Female|Unique astrocytoma variants|2007-2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|112|571759383|Female|Unique astrocytoma variants|2007-2011|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|54|114027722|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|70|115293599|Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|62|116607751|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|116607751|Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|70|116884558|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|116884558|Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|103190694|Male|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|104488268|Male|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|105697783|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|66|536385009|Male|All other|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|536385009|Male|All other|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|21|106947980|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|109537492|Male|All other|2010|~|~|~
20+|~|~|~|Malignant|~|109537492|Male|All other|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|109887942|Male|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|19|109887942|Male|All other|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|667|101938779|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|689|103190694|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|691|104488268|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|661|105697783|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|536385009|Male|Anaplastic astrocytoma|2007-2011|~|~|~
20+|0.6|0.7|0.6|Malignant|3438|536385009|Male|Anaplastic astrocytoma|2007-2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|706|106947980|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.7|Malignant|705|108197539|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109537492|Male|Anaplastic astrocytoma|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|686|109537492|Male|Anaplastic astrocytoma|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|109887942|Male|Anaplastic astrocytoma|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|696|109887942|Male|Anaplastic astrocytoma|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|201|101938779|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|202|103190694|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|212|104488268|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|177|105697783|Male|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|536385009|Male|Anaplastic oligodendroglioma|2007-2011|~|~|~
20+|0.2|0.2|0.2|Malignant|891|536385009|Male|Anaplastic oligodendroglioma|2007-2011|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|185|106947980|Male|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|181|108197539|Male|Anaplastic oligodendroglioma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109537492|Male|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|183|109537492|Male|Anaplastic oligodendroglioma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109887942|Male|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|171|109887942|Male|Anaplastic oligodendroglioma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|632|101938779|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|630|103190694|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|645|104488268|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|621|105697783|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|536385009|Male|Astrocytoma, NOS|2007-2011|~|~|~
20+|0.5|0.6|0.6|Malignant|2933|536385009|Male|Astrocytoma, NOS|2007-2011|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|615|106947980|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|566|108197539|Male|Astrocytoma, NOS|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109537492|Male|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.6|0.5|Malignant|597|109537492|Male|Astrocytoma, NOS|2010|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109887942|Male|Astrocytoma, NOS|2011|~|~|~
20+|0.5|0.5|0.5|Malignant|544|109887942|Male|Astrocytoma, NOS|2011|0.5|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|22|101938779|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|103190694|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|105697783|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|145|536385009|Male|Choroid plexus|2007-2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|536385009|Male|Choroid plexus|2007-2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|25|106947980|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|108197539|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|109537492|Male|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109537492|Male|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|109887942|Male|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109887942|Male|Choroid plexus|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|180|101938779|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|103190694|Male|Craniopharyngioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|184|104488268|Male|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|189|105697783|Male|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|944|536385009|Male|Craniopharyngioma|2007-2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|536385009|Male|Craniopharyngioma|2007-2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|193|106947980|Male|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|197|108197539|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|192|109537492|Male|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109537492|Male|Craniopharyngioma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|178|109887942|Male|Craniopharyngioma|2011|0.1|0.2|0.2
20+|~|~|~|Malignant|~|109887942|Male|Craniopharyngioma|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|142|101938779|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|103190694|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|182|105697783|Male|Diffuse astrocytoma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|536385009|Male|Diffuse astrocytoma|2007-2011|~|~|~
20+|0.2|0.2|0.2|Malignant|901|536385009|Male|Diffuse astrocytoma|2007-2011|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|206|106947980|Male|Diffuse astrocytoma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.2|0.2|0.2|Malignant|201|108197539|Male|Diffuse astrocytoma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109537492|Male|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|185|109537492|Male|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109887942|Male|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|135|109887942|Male|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|96|101938779|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|104|103190694|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|96|104488268|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|536385009|Male|Embryonal/primitive/medulloblastoma|2007-2011|~|~|~
20+|0.1|0.1|0.1|Malignant|615|536385009|Male|Embryonal/primitive/medulloblastoma|2007-2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|123|106947980|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|131|108197539|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109537492|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|124|109537492|Male|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109887942|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|115|109887942|Male|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|140|101938779|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|103190694|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|157|104488268|Male|Ependymoma variants|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|136|105697783|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|709|536385009|Male|Ependymoma variants|2007-2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|536385009|Male|Ependymoma variants|2007-2011|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|144|106947980|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|144|108197539|Male|Ependymoma variants|2009|0.1|0.2|0.1
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|149|109537492|Male|Ependymoma variants|2010|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109537492|Male|Ependymoma variants|2010|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|141|109887942|Male|Ependymoma variants|2011|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109887942|Male|Ependymoma variants|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|295|101938779|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|298|103190694|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|284|104488268|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|281|105697783|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|33|536385009|Male|Ependymoma/anaplastic ependymoma|2007-2011|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|1511|536385009|Male|Ependymoma/anaplastic ependymoma|2007-2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|315|106947980|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|327|108197539|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109537492|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|316|109537492|Male|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109887942|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|282|109887942|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|21|101938779|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|42|101938779|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|27|103190694|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|52|103190694|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|28|104488268|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|45|104488268|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|105697783|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|75|105697783|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|129|536385009|Male|Germ Cell Tumors|2007-2011|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|273|536385009|Male|Germ Cell Tumors|2007-2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|28|106947980|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|53|106947980|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|22|109537492|Male|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|56|109537492|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|21|109887942|Male|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|55|109887942|Male|Germ Cell Tumors|2011|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5471|101938779|Male|Glioblastoma|2004|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005|~|~|~
20+|5.4|5.7|5.6|Malignant|5511|103190694|Male|Glioblastoma|2005|5.2|5.5|5.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.4|Malignant|5501|104488268|Male|Glioblastoma|2006|5.1|5.4|5.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007|~|~|~
20+|5.4|5.7|5.6|Malignant|5801|105697783|Male|Glioblastoma|2007|5.3|5.6|5.5
20+|~|~|~|Benign/Borderline|~|536385009|Male|Glioblastoma|2007-2011|~|~|~
20+|5.5|5.6|5.5|Malignant|29717|536385009|Male|Glioblastoma|2007-2011|5.5|5.6|5.5
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.6|Malignant|5975|106947980|Male|Glioblastoma|2008|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009|~|~|~
20+|5.4|5.7|5.5|Malignant|5973|108197539|Male|Glioblastoma|2009|5.4|5.7|5.5
20+|~|~|~|Benign/Borderline|~|109537492|Male|Glioblastoma|2010|~|~|~
20+|5.3|5.6|5.4|Malignant|6051|109537492|Male|Glioblastoma|2010|5.4|5.7|5.5
20+|~|~|~|Benign/Borderline|~|109887942|Male|Glioblastoma|2011|~|~|~
20+|5.3|5.6|5.4|Malignant|6114|109887942|Male|Glioblastoma|2011|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|423|101938779|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|437|103190694|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|439|104488268|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.4|Malignant|449|105697783|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|55|536385009|Male|Glioma malignant, NOS|2007-2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|2184|536385009|Male|Glioma malignant, NOS|2007-2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioma malignant, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|459|106947980|Male|Glioma malignant, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|437|108197539|Male|Glioma malignant, NOS|2009|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109537492|Male|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|400|109537492|Male|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109887942|Male|Glioma malignant, NOS|2011|~|~|~
20+|0.4|0.5|0.4|Malignant|452|109887942|Male|Glioma malignant, NOS|2011|0.4|0.5|0.4
20+|0.2|0.3|0.2|Benign/Borderline|241|101938779|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|279|103190694|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|274|104488268|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|250|105697783|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|1344|536385009|Male|Hemangioblastoma|2007-2011|0.2|0.3|0.3
20+|~|~|~|Malignant|~|536385009|Male|Hemangioblastoma|2007-2011|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|287|106947980|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|265|108197539|Male|Hemangioblastoma|2009|0.2|0.3|0.2
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|293|109537492|Male|Hemangioblastoma|2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|109537492|Male|Hemangioblastoma|2010|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|257|109887942|Male|Hemangioblastoma|2011|0.2|0.3|0.2
20+|~|~|~|Malignant|~|109887942|Male|Hemangioblastoma|2011|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|128|101938779|Male|Hemangioma|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|184|103190694|Male|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|221|104488268|Male|Hemangioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|254|105697783|Male|Hemangioma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|1815|536385009|Male|Hemangioma|2007-2011|0.3|0.4|0.3
20+|~|~|~|Malignant|~|536385009|Male|Hemangioma|2007-2011|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|309|106947980|Male|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|396|108197539|Male|Hemangioma|2009|0.3|0.4|0.4
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|405|109537492|Male|Hemangioma|2010|0.3|0.4|0.4
20+|~|~|~|Malignant|~|109537492|Male|Hemangioma|2010|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|453|109887942|Male|Hemangioma|2011|0.4|0.5|0.4
20+|~|~|~|Malignant|~|109887942|Male|Hemangioma|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|101938779|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|24|103190694|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|33|104488268|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|536385009|Male|Local Extensions from Regional Tumors|2007-2011|~|~|~
20+|0.0|0.0|0.0|Malignant|128|536385009|Male|Local Extensions from Regional Tumors|2007-2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|30|106947980|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|27|108197539|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109537492|Male|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|27|109537492|Male|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109887942|Male|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|22|109887942|Male|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|744|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|770|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|753|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|731|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|536385009|Male|Lymphomas and Hematopoietic Neoplasms|2007-2011|~|~|~
20+|0.7|0.7|0.7|Malignant|3753|536385009|Male|Lymphomas and Hematopoietic Neoplasms|2007-2011|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.7|Malignant|769|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.7|0.8|0.7|Malignant|753|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109537492|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.7|Malignant|747|109537492|Male|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109887942|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.7|0.8|0.7|Malignant|778|109887942|Male|Lymphomas and Hematopoietic Neoplasms|2011|0.7|0.8|0.7
20+|4.9|5.2|5.1|Benign/Borderline|4748|101938779|Male|Meningioma|2004|4.5|4.8|4.7
20+|0.2|0.2|0.2|Malignant|168|101938779|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.4|5.7|5.6|Benign/Borderline|5291|103190694|Male|Meningioma|2005|5.0|5.3|5.1
20+|0.1|0.2|0.2|Malignant|157|103190694|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.7|6.0|5.8|Benign/Borderline|5652|104488268|Male|Meningioma|2006|5.3|5.6|5.4
20+|0.1|0.2|0.2|Malignant|149|104488268|Male|Meningioma|2006|0.1|0.2|0.1
20+|5.7|6.0|5.9|Benign/Borderline|5814|105697783|Male|Meningioma|2007|5.4|5.6|5.5
20+|0.1|0.2|0.2|Malignant|178|105697783|Male|Meningioma|2007|0.1|0.2|0.2
20+|6.2|6.3|6.2|Benign/Borderline|31953|536385009|Male|Meningioma|2007-2011|5.9|6.0|6.0
20+|0.1|0.1|0.1|Malignant|715|536385009|Male|Meningioma|2007-2011|0.1|0.1|0.1
20+|6.1|6.4|6.2|Benign/Borderline|6327|106947980|Male|Meningioma|2008|5.8|6.1|5.9
20+|0.1|0.2|0.1|Malignant|148|106947980|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.4|6.7|6.6|Benign/Borderline|6738|108197539|Male|Meningioma|2009|6.1|6.4|6.2
20+|0.1|0.2|0.1|Malignant|142|108197539|Male|Meningioma|2009|0.1|0.2|0.1
20+|6.1|6.5|6.3|Benign/Borderline|6620|109537492|Male|Meningioma|2010|5.9|6.2|6.0
20+|0.1|0.1|0.1|Malignant|115|109537492|Male|Meningioma|2010|0.1|0.1|0.1
20+|6.1|6.4|6.2|Benign/Borderline|6631|109887942|Male|Meningioma|2011|5.9|6.2|6.0
20+|0.1|0.1|0.1|Malignant|132|109887942|Male|Meningioma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|284|101938779|Male|Mixed glioma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|329|103190694|Male|Mixed glioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|360|104488268|Male|Mixed glioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|342|105697783|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|536385009|Male|Mixed glioma|2007-2011|~|~|~
20+|0.3|0.3|0.3|Malignant|1723|536385009|Male|Mixed glioma|2007-2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|327|106947980|Male|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.3|Malignant|378|108197539|Male|Mixed glioma|2009|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|109537492|Male|Mixed glioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|337|109537492|Male|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109887942|Male|Mixed glioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|349|109887942|Male|Mixed glioma|2011|0.3|0.4|0.3
20+|0.5|0.6|0.5|Benign/Borderline|495|101938779|Male|Neoplasm, unspecified|2004|0.4|0.5|0.5
20+|0.6|0.8|0.7|Malignant|619|101938779|Male|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|616|103190694|Male|Neoplasm, unspecified|2005|0.6|0.6|0.6
20+|0.6|0.7|0.7|Malignant|608|103190694|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|598|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|575|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|575|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.6|0.7|0.6|Malignant|572|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|2941|536385009|Male|Neoplasm, unspecified|2007-2011|0.5|0.6|0.5
20+|0.6|0.6|0.6|Malignant|2982|536385009|Male|Neoplasm, unspecified|2007-2011|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|589|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|624|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|600|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|639|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|618|109537492|Male|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|588|109537492|Male|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.5|0.6|0.5|Benign/Borderline|568|109887942|Male|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.5|0.6|0.6|Malignant|597|109887942|Male|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|2.1|2.3|2.2|Benign/Borderline|2233|101938779|Male|Nerve sheath, benign and malignant|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2581|103190694|Male|Nerve sheath, benign and malignant|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|29|103190694|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2526|104488268|Male|Nerve sheath, benign and malignant|2006|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2580|105697783|Male|Nerve sheath, benign and malignant|2007|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.3|2.3|2.3|Benign/Borderline|12659|536385009|Male|Nerve sheath, benign and malignant|2007-2011|2.3|2.4|2.4
20+|0.0|0.0|0.0|Malignant|102|536385009|Male|Nerve sheath, benign and malignant|2007-2011|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2533|106947980|Male|Nerve sheath, benign and malignant|2008|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|24|106947980|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2630|108197539|Male|Nerve sheath, benign and malignant|2009|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.2|2.3|2.3|Benign/Borderline|2540|109537492|Male|Nerve sheath, benign and malignant|2010|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|22|109537492|Male|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.1|2.2|2.1|Benign/Borderline|2442|109887942|Male|Nerve sheath, benign and malignant|2011|2.1|2.3|2.2
20+|~|~|~|Malignant|~|109887942|Male|Nerve sheath, benign and malignant|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|32|105697783|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|536385009|Male|Neuroepithelial|2007-2011|~|~|~
20+|0.0|0.0|0.0|Malignant|124|536385009|Male|Neuroepithelial|2007-2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|22|108197539|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109537492|Male|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|27|109537492|Male|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109887942|Male|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|25|109887942|Male|Neuroepithelial|2011|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|155|101938779|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|101938779|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|182|103190694|Male|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|34|103190694|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|189|104488268|Male|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|178|105697783|Male|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|980|536385009|Male|Neuronal/glial, neuronal|2007-2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|98|536385009|Male|Neuronal/glial, neuronal|2007-2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|208|106947980|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|106947980|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|213|108197539|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|218|109537492|Male|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109537492|Male|Neuronal/glial, neuronal|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|170|109887942|Male|Neuronal/glial, neuronal|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|109887942|Male|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.5|Malignant|471|101938779|Male|Oligodendroglioma|2004|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.5|0.4|Malignant|427|103190694|Male|Oligodendroglioma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|449|104488268|Male|Oligodendroglioma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|425|105697783|Male|Oligodendroglioma|2007|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|536385009|Male|Oligodendroglioma|2007-2011|~|~|~
20+|0.4|0.4|0.4|Malignant|2116|536385009|Male|Oligodendroglioma|2007-2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|389|106947980|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|454|108197539|Male|Oligodendroglioma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109537492|Male|Oligodendroglioma|2010|~|~|~
20+|0.4|0.5|0.4|Malignant|444|109537492|Male|Oligodendroglioma|2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109887942|Male|Oligodendroglioma|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|417|109887942|Male|Oligodendroglioma|2011|0.3|0.4|0.4
20+|0.1|0.1|0.1|Benign/Borderline|80|101938779|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|69|103190694|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|68|104488268|Male|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|104488268|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|84|105697783|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|105697783|Male|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|410|536385009|Male|Other mesenchymal|2007-2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|197|536385009|Male|Other mesenchymal|2007-2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|106947980|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|43|106947980|Male|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|98|108197539|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|108197539|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|74|109537492|Male|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|109537492|Male|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|60|109887942|Male|Other mesenchymal|2011|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|42|109887942|Male|Other mesenchymal|2011|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|149|101938779|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|155|103190694|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|158|104488268|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|141|105697783|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|536385009|Male|Pilocytic astrocytoma|2007-2011|~|~|~
20+|0.1|0.1|0.1|Malignant|736|536385009|Male|Pilocytic astrocytoma|2007-2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|144|106947980|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|134|108197539|Male|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109537492|Male|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|161|109537492|Male|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109887942|Male|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|157|109887942|Male|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Pineal parenchymal|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|75|536385009|Male|Pineal parenchymal|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|85|536385009|Male|Pineal parenchymal|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|21|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109537492|Male|Pineal parenchymal|2010|~|~|~
20+|~|~|~|Malignant|~|109537492|Male|Pineal parenchymal|2010|~|~|~
20+|~|~|~|Benign/Borderline|~|109887942|Male|Pineal parenchymal|2011|~|~|~
20+|~|~|~|Malignant|~|109887942|Male|Pineal parenchymal|2011|~|~|~
20+|3.1|3.4|3.2|Benign/Borderline|3221|101938779|Male|Pituitary|2004|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|19|101938779|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.4|3.6|3.5|Benign/Borderline|3533|103190694|Male|Pituitary|2005|3.3|3.5|3.4
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005|~|~|~
20+|3.6|3.8|3.7|Benign/Borderline|3801|104488268|Male|Pituitary|2006|3.5|3.8|3.6
20+|0.0|0.0|0.0|Malignant|17|104488268|Male|Pituitary|2006|0.0|0.0|0.0
20+|3.8|4.0|3.9|Benign/Borderline|4109|105697783|Male|Pituitary|2007|3.8|4.0|3.9
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Pituitary|2007|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|22520|536385009|Male|Pituitary|2007-2011|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|63|536385009|Male|Pituitary|2007-2011|0.0|0.0|0.0
20+|4.1|4.4|4.2|Benign/Borderline|4472|106947980|Male|Pituitary|2008|4.1|4.3|4.2
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008|~|~|~
20+|4.2|4.5|4.3|Benign/Borderline|4697|108197539|Male|Pituitary|2009|4.2|4.5|4.3
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009|~|~|~
20+|4.1|4.4|4.3|Benign/Borderline|4702|109537492|Male|Pituitary|2010|4.2|4.4|4.3
20+|~|~|~|Malignant|~|109537492|Male|Pituitary|2010|~|~|~
20+|4.1|4.3|4.2|Benign/Borderline|4648|109887942|Male|Pituitary|2011|4.1|4.4|4.2
20+|~|~|~|Malignant|~|109887942|Male|Pituitary|2011|~|~|~
20+|11.9|12.3|12.1|Benign/Borderline|11785|101938779|Male|Total|2004|11.4|11.8|11.6
20+|10.6|11.0|10.8|Malignant|10596|101938779|Male|Total|2004|10.2|10.6|10.4
20+|13.2|13.7|13.5|Benign/Borderline|13312|103190694|Male|Total|2005|12.7|13.1|12.9
20+|10.6|11.0|10.8|Malignant|10725|103190694|Male|Total|2005|10.2|10.6|10.4
20+|13.6|14.0|13.8|Benign/Borderline|13891|104488268|Male|Total|2006|13.1|13.5|13.3
20+|10.4|10.8|10.6|Malignant|10766|104488268|Male|Total|2006|10.1|10.5|10.3
20+|13.8|14.3|14.0|Benign/Borderline|14391|105697783|Male|Total|2007|13.4|13.8|13.6
20+|10.4|10.8|10.6|Malignant|10978|105697783|Male|Total|2007|10.2|10.6|10.4
20+|14.6|14.8|14.7|Benign/Borderline|77490|536385009|Male|Total|2007-2011|14.3|14.5|14.4
20+|10.3|10.5|10.4|Malignant|55531|536385009|Male|Total|2007-2011|10.3|10.4|10.4
20+|14.5|15.0|14.8|Benign/Borderline|15396|106947980|Male|Total|2008|14.2|14.6|14.4
20+|10.5|10.9|10.7|Malignant|11253|106947980|Male|Total|2008|10.3|10.7|10.5
20+|15.1|15.6|15.3|Benign/Borderline|16220|108197539|Male|Total|2009|14.8|15.2|15.0
20+|10.3|10.7|10.5|Malignant|11267|108197539|Male|Total|2009|10.2|10.6|10.4
20+|14.6|15.1|14.8|Benign/Borderline|16069|109537492|Male|Total|2010|14.4|14.9|14.7
20+|10.0|10.4|10.2|Malignant|11185|109537492|Male|Total|2010|10.0|10.4|10.2
20+|14.2|14.7|14.5|Benign/Borderline|15811|109887942|Male|Total|2011|14.2|14.6|14.4
20+|9.9|10.3|10.1|Malignant|11204|109887942|Male|Total|2011|10.0|10.4|10.2
20+|2.1|2.3|2.2|Benign/Borderline|2233|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2581|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|29|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2527|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2581|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.3|2.3|2.3|Benign/Borderline|12669|536385009|Male|Tumors of Cranial and Spinal Nerves|2007-2011|2.3|2.4|2.4
20+|0.0|0.0|0.0|Malignant|102|536385009|Male|Tumors of Cranial and Spinal Nerves|2007-2011|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2535|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|24|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2633|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.2|2.3|2.3|Benign/Borderline|2541|109537492|Male|Tumors of Cranial and Spinal Nerves|2010|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|22|109537492|Male|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.1|2.2|2.2|Benign/Borderline|2445|109887942|Male|Tumors of Cranial and Spinal Nerves|2011|2.1|2.3|2.2
20+|~|~|~|Malignant|~|109887942|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|434|101938779|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.9|9.2|9.1|Malignant|8920|101938779|Male|Tumors of Neuroepthelial Tissue|2004|8.6|8.9|8.8
20+|0.4|0.5|0.5|Benign/Borderline|504|103190694|Male|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
20+|8.9|9.2|9.0|Malignant|9024|103190694|Male|Tumors of Neuroepthelial Tissue|2005|8.6|8.9|8.7
20+|0.5|0.6|0.5|Benign/Borderline|534|104488268|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
20+|8.8|9.1|9.0|Malignant|9132|104488268|Male|Tumors of Neuroepthelial Tissue|2006|8.6|8.9|8.7
20+|0.4|0.5|0.5|Benign/Borderline|503|105697783|Male|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|8.8|9.1|8.9|Malignant|9308|105697783|Male|Tumors of Neuroepthelial Tissue|2007|8.6|9.0|8.8
20+|0.5|0.5|0.5|Benign/Borderline|2749|536385009|Male|Tumors of Neuroepthelial Tissue|2007-2011|0.5|0.5|0.5
20+|8.7|8.9|8.8|Malignant|47250|536385009|Male|Tumors of Neuroepthelial Tissue|2007-2011|8.7|8.9|8.8
20+|0.5|0.6|0.5|Benign/Borderline|556|106947980|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9544|106947980|Male|Tumors of Neuroepthelial Tissue|2008|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|564|108197539|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
20+|8.7|9.1|8.9|Malignant|9586|108197539|Male|Tumors of Neuroepthelial Tissue|2009|8.7|9.0|8.9
20+|0.5|0.6|0.6|Benign/Borderline|599|109537492|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.5
20+|8.5|8.9|8.7|Malignant|9571|109537492|Male|Tumors of Neuroepthelial Tissue|2010|8.6|8.9|8.7
20+|0.5|0.5|0.5|Benign/Borderline|547|109887942|Male|Tumors of Neuroepthelial Tissue|2011|0.5|0.5|0.5
20+|8.4|8.7|8.5|Malignant|9528|109887942|Male|Tumors of Neuroepthelial Tissue|2011|8.5|8.8|8.7
20+|3.3|3.5|3.4|Benign/Borderline|3401|101938779|Male|Tumors of Sellar Region|2004|3.2|3.5|3.3
20+|0.0|0.0|0.0|Malignant|19|101938779|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.6|3.9|3.7|Benign/Borderline|3760|103190694|Male|Tumors of Sellar Region|2005|3.5|3.8|3.6
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005|~|~|~
20+|3.8|4.0|3.9|Benign/Borderline|3985|104488268|Male|Tumors of Sellar Region|2006|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.0|4.2|4.1|Benign/Borderline|4298|105697783|Male|Tumors of Sellar Region|2007|3.9|4.2|4.1
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.3|4.4|4.4|Benign/Borderline|23464|536385009|Male|Tumors of Sellar Region|2007-2011|4.3|4.4|4.4
20+|0.0|0.0|0.0|Malignant|64|536385009|Male|Tumors of Sellar Region|2007-2011|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|4665|106947980|Male|Tumors of Sellar Region|2008|4.2|4.5|4.4
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.4|4.6|4.5|Benign/Borderline|4894|108197539|Male|Tumors of Sellar Region|2009|4.4|4.7|4.5
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009|~|~|~
20+|4.3|4.6|4.4|Benign/Borderline|4894|109537492|Male|Tumors of Sellar Region|2010|4.3|4.6|4.5
20+|~|~|~|Malignant|~|109537492|Male|Tumors of Sellar Region|2010|~|~|~
20+|4.2|4.5|4.4|Benign/Borderline|4826|109887942|Male|Tumors of Sellar Region|2011|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|16|109887942|Male|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|5069|101938779|Male|Tumors of the Meninges|2004|4.8|5.1|5.0
20+|0.2|0.2|0.2|Malignant|195|101938779|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|5.8|6.1|5.9|Benign/Borderline|5639|103190694|Male|Tumors of the Meninges|2005|5.3|5.6|5.5
20+|0.2|0.2|0.2|Malignant|195|103190694|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|6.0|6.3|6.2|Benign/Borderline|5994|104488268|Male|Tumors of the Meninges|2006|5.6|5.9|5.7
20+|0.2|0.2|0.2|Malignant|181|104488268|Male|Tumors of the Meninges|2006|0.1|0.2|0.2
20+|6.0|6.4|6.2|Benign/Borderline|6148|105697783|Male|Tumors of the Meninges|2007|5.7|6.0|5.8
20+|0.2|0.2|0.2|Malignant|218|105697783|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.5|6.6|6.6|Benign/Borderline|33707|536385009|Male|Tumors of the Meninges|2007-2011|6.2|6.4|6.3
20+|0.2|0.2|0.2|Malignant|922|536385009|Male|Tumors of the Meninges|2007-2011|0.2|0.2|0.2
20+|6.4|6.8|6.6|Benign/Borderline|6709|106947980|Male|Tumors of the Meninges|2008|6.1|6.4|6.3
20+|0.2|0.2|0.2|Malignant|195|106947980|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|6.7|7.1|6.9|Benign/Borderline|7101|108197539|Male|Tumors of the Meninges|2009|6.4|6.7|6.6
20+|0.2|0.2|0.2|Malignant|189|108197539|Male|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|6.5|6.8|6.6|Benign/Borderline|6987|109537492|Male|Tumors of the Meninges|2010|6.2|6.5|6.4
20+|0.1|0.2|0.1|Malignant|147|109537492|Male|Tumors of the Meninges|2010|0.1|0.2|0.1
20+|6.3|6.7|6.5|Benign/Borderline|6948|109887942|Male|Tumors of the Meninges|2011|6.2|6.5|6.3
20+|0.1|0.2|0.2|Malignant|175|109887942|Male|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|0.6|0.7|0.7|Benign/Borderline|625|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Malignant|626|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.8|Benign/Borderline|801|103190694|Male|Unclassified Tumors|2005|0.7|0.8|0.8
20+|0.6|0.7|0.7|Malignant|617|103190694|Male|Unclassified Tumors|2005|0.6|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|821|104488268|Male|Unclassified Tumors|2006|0.7|0.8|0.8
20+|0.6|0.7|0.6|Malignant|586|104488268|Male|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|830|105697783|Male|Unclassified Tumors|2007|0.7|0.8|0.8
20+|0.6|0.7|0.6|Malignant|579|105697783|Male|Unclassified Tumors|2007|0.5|0.6|0.5
20+|0.9|1.0|0.9|Benign/Borderline|4767|536385009|Male|Unclassified Tumors|2007-2011|0.9|0.9|0.9
20+|0.6|0.6|0.6|Malignant|3039|536385009|Male|Unclassified Tumors|2007-2011|0.5|0.6|0.6
20+|0.8|1.0|0.9|Benign/Borderline|902|106947980|Male|Unclassified Tumors|2008|0.8|0.9|0.8
20+|0.6|0.7|0.7|Malignant|633|106947980|Male|Unclassified Tumors|2008|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|998|108197539|Male|Unclassified Tumors|2009|0.9|1.0|0.9
20+|0.6|0.7|0.7|Malignant|649|108197539|Male|Unclassified Tumors|2009|0.6|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1025|109537492|Male|Unclassified Tumors|2010|0.9|1.0|0.9
20+|0.6|0.6|0.6|Malignant|601|109537492|Male|Unclassified Tumors|2010|0.5|0.6|0.5
20+|0.9|1.0|0.9|Benign/Borderline|1023|109887942|Male|Unclassified Tumors|2011|0.9|1.0|0.9
20+|0.6|0.7|0.6|Malignant|615|109887942|Male|Unclassified Tumors|2011|0.5|0.6|0.6
20+|0.1|0.1|0.1|Benign/Borderline|96|101938779|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|101938779|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|109|103190694|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|130|104488268|Male|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|24|104488268|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|119|105697783|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|105697783|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|728|536385009|Male|Unique astrocytoma variants|2007-2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|154|536385009|Male|Unique astrocytoma variants|2007-2011|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|141|106947980|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|33|106947980|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|146|108197539|Male|Unique astrocytoma variants|2009|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|108197539|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|165|109537492|Male|Unique astrocytoma variants|2010|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|25|109537492|Male|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|162|109887942|Male|Unique astrocytoma variants|2011|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|30|109887942|Male|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|211050944|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|213511339|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|216055494|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|218481776|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|144|1108144392|Male and Female|All other|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|78|1108144392|Male and Female|All other|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|35|220975702|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|25|223491138|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|226145243|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|226145243|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|226772500|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|34|226772500|Male and Female|All other|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1232|211050944|Male and Female|Anaplastic astrocytoma|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1201|213511339|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1197|216055494|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1191|218481776|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Anaplastic astrocytoma|2007-2011|~|~|~
20+|0.5|0.6|0.5|Malignant|6055|1108144392|Male and Female|Anaplastic astrocytoma|2007-2011|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1201|220975702|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|1200|223491138|Male and Female|Anaplastic astrocytoma|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.5|0.6|0.5|Malignant|1243|226145243|Male and Female|Anaplastic astrocytoma|2010|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|1249|226772500|Male and Female|Anaplastic astrocytoma|2011|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|382|211050944|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|367|213511339|Male and Female|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|348|216055494|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|328|218481776|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Anaplastic oligodendroglioma|2007-2011|~|~|~
20+|0.1|0.2|0.1|Malignant|1615|1108144392|Male and Female|Anaplastic oligodendroglioma|2007-2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|350|220975702|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|322|223491138|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|311|226145243|Male and Female|Anaplastic oligodendroglioma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|313|226772500|Male and Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1202|211050944|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1185|213511339|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.5|Malignant|1180|216055494|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1147|218481776|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Astrocytoma, NOS|2007-2011|~|~|~
20+|0.5|0.5|0.5|Malignant|5303|1108144392|Male and Female|Astrocytoma, NOS|2007-2011|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1098|220975702|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.5|Malignant|1045|223491138|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|1058|226145243|Male and Female|Astrocytoma, NOS|2010|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Astrocytoma, NOS|2011|~|~|~
20+|0.4|0.5|0.4|Malignant|976|226772500|Male and Female|Astrocytoma, NOS|2011|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|60|211050944|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|73|213511339|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|67|216055494|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|84|218481776|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|383|1108144392|Male and Female|Choroid plexus|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|1108144392|Male and Female|Choroid plexus|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|71|220975702|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|223491138|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|80|226145243|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226145243|Male and Female|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|78|226772500|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226772500|Male and Female|Choroid plexus|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|372|211050944|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|407|213511339|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|380|216055494|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|404|218481776|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2022|1108144392|Male and Female|Craniopharyngioma|2007-2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1108144392|Male and Female|Craniopharyngioma|2007-2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|410|220975702|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|416|223491138|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|418|226145243|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226145243|Male and Female|Craniopharyngioma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|383|226772500|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226772500|Male and Female|Craniopharyngioma|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|255|211050944|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|280|213511339|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|293|216055494|Male and Female|Diffuse astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|314|218481776|Male and Female|Diffuse astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Diffuse astrocytoma|2007-2011|~|~|~
20+|0.1|0.1|0.1|Malignant|1600|1108144392|Male and Female|Diffuse astrocytoma|2007-2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|342|220975702|Male and Female|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|361|223491138|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|346|226145243|Male and Female|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|246|226772500|Male and Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|165|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|188|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|169|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|214|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Embryonal/primitive/medulloblastoma|2007-2011|~|~|~
20+|0.1|0.1|0.1|Malignant|1032|1108144392|Male and Female|Embryonal/primitive/medulloblastoma|2007-2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|210|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|235|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|197|226145243|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|181|226772500|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|245|211050944|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|265|213511339|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|303|216055494|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|247|218481776|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|1267|1108144392|Male and Female|Ependymoma variants|2007-2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|1108144392|Male and Female|Ependymoma variants|2007-2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|251|220975702|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|256|223491138|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|266|226145243|Male and Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226145243|Male and Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|253|226772500|Male and Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226772500|Male and Female|Ependymoma variants|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|587|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|597|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|576|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|572|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|64|1108144392|Male and Female|Ependymoma/anaplastic ependymoma|2007-2011|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|3008|1108144392|Male and Female|Ependymoma/anaplastic ependymoma|2007-2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|624|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|662|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|606|226145243|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|226772500|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|565|226772500|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|38|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|62|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|65|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|80|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|291|1108144392|Male and Female|Germ Cell Tumors|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|313|1108144392|Male and Female|Germ Cell Tumors|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|59|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|65|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|51|226145243|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|226145243|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|52|226772500|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|63|226772500|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9555|211050944|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005|~|~|~
20+|4.3|4.5|4.4|Malignant|9657|213511339|Male and Female|Glioblastoma|2005|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9780|216055494|Male and Female|Glioblastoma|2006|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|10163|218481776|Male and Female|Glioblastoma|2007|4.6|4.7|4.7
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Glioblastoma|2007-2011|~|~|~
20+|4.4|4.5|4.4|Malignant|51881|1108144392|Male and Female|Glioblastoma|2007-2011|4.6|4.7|4.7
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10372|220975702|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009|~|~|~
20+|4.3|4.5|4.4|Malignant|10413|223491138|Male and Female|Glioblastoma|2009|4.6|4.7|4.7
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Glioblastoma|2010|~|~|~
20+|4.3|4.5|4.4|Malignant|10621|226145243|Male and Female|Glioblastoma|2010|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Glioblastoma|2011|~|~|~
20+|4.3|4.4|4.3|Malignant|10619|226772500|Male and Female|Glioblastoma|2011|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|842|211050944|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|823|213511339|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|829|216055494|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|853|218481776|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|94|1108144392|Male and Female|Glioma malignant, NOS|2007-2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|4290|1108144392|Male and Female|Glioma malignant, NOS|2007-2011|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|20|220975702|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|889|220975702|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|21|223491138|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|935|223491138|Male and Female|Glioma malignant, NOS|2009|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|226145243|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|785|226145243|Male and Female|Glioma malignant, NOS|2010|0.3|0.4|0.3
20+|0.0|0.0|0.0|Benign/Borderline|22|226772500|Male and Female|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|853|226772500|Male and Female|Glioma malignant, NOS|2011|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|443|211050944|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|499|213511339|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|488|216055494|Male and Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|456|218481776|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2445|1108144392|Male and Female|Hemangioblastoma|2007-2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1108144392|Male and Female|Hemangioblastoma|2007-2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|520|220975702|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|489|223491138|Male and Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|509|226145243|Male and Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226145243|Male and Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|484|226772500|Male and Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226772500|Male and Female|Hemangioblastoma|2011|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|351|211050944|Male and Female|Hemangioma|2004|0.1|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|451|213511339|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|520|216055494|Male and Female|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|599|218481776|Male and Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|4291|1108144392|Male and Female|Hemangioma|2007-2011|0.4|0.4|0.4
20+|0.0|0.0|0.0|Malignant|23|1108144392|Male and Female|Hemangioma|2007-2011|0.0|0.0|0.0
20+|0.3|0.4|0.3|Benign/Borderline|736|220975702|Male and Female|Hemangioma|2008|0.3|0.4|0.3
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|871|223491138|Male and Female|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|998|226145243|Male and Female|Hemangioma|2010|0.4|0.5|0.4
20+|~|~|~|Malignant|~|226145243|Male and Female|Hemangioma|2010|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|1093|226772500|Male and Female|Hemangioma|2011|0.5|0.5|0.5
20+|~|~|~|Malignant|~|226772500|Male and Female|Hemangioma|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|46|213511339|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|50|216055494|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Local Extensions from Regional Tumors|2007-2011|~|~|~
20+|0.0|0.0|0.0|Malignant|239|1108144392|Male and Female|Local Extensions from Regional Tumors|2007-2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|51|223491138|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|48|226145243|Male and Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|43|226772500|Male and Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1337|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1429|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1424|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.6|0.6|Malignant|1362|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007-2011|~|~|~
20+|0.6|0.6|0.6|Malignant|7161|1108144392|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007-2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|1465|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.6|0.6|Malignant|1411|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|1492|226145243|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|1477|226772500|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.7
20+|8.5|8.7|8.6|Benign/Borderline|18318|211050944|Male and Female|Meningioma|2004|8.6|8.8|8.7
20+|0.2|0.2|0.2|Malignant|443|211050944|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|9.5|9.8|9.6|Benign/Borderline|20782|213511339|Male and Female|Meningioma|2005|9.6|9.9|9.7
20+|0.2|0.2|0.2|Malignant|434|213511339|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|9.9|10.2|10.0|Benign/Borderline|22045|216055494|Male and Female|Meningioma|2006|10.1|10.3|10.2
20+|0.2|0.2|0.2|Malignant|401|216055494|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|10.1|10.4|10.2|Benign/Borderline|22879|218481776|Male and Female|Meningioma|2007|10.3|10.6|10.5
20+|0.2|0.2|0.2|Malignant|446|218481776|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|10.6|10.7|10.6|Benign/Borderline|122418|1108144392|Male and Female|Meningioma|2007-2011|11.0|11.1|11.0
20+|0.1|0.2|0.2|Malignant|1748|1108144392|Male and Female|Meningioma|2007-2011|0.2|0.2|0.2
20+|10.5|10.8|10.7|Benign/Borderline|24370|220975702|Male and Female|Meningioma|2008|10.9|11.2|11.0
20+|0.1|0.2|0.2|Malignant|358|220975702|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|11.1|11.3|11.2|Benign/Borderline|26005|223491138|Male and Female|Meningioma|2009|11.5|11.8|11.6
20+|0.1|0.2|0.1|Malignant|341|223491138|Male and Female|Meningioma|2009|0.1|0.2|0.2
20+|10.4|10.7|10.6|Benign/Borderline|25025|226145243|Male and Female|Meningioma|2010|10.9|11.2|11.1
20+|0.1|0.1|0.1|Malignant|305|226145243|Male and Female|Meningioma|2010|0.1|0.2|0.1
20+|10.3|10.5|10.4|Benign/Borderline|24780|226772500|Male and Female|Meningioma|2011|10.8|11.1|10.9
20+|0.1|0.1|0.1|Malignant|303|226772500|Male and Female|Meningioma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|479|211050944|Male and Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|564|213511339|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|627|216055494|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|578|218481776|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Mixed glioma|2007-2011|~|~|~
20+|0.3|0.3|0.3|Malignant|3013|1108144392|Male and Female|Mixed glioma|2007-2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|585|220975702|Male and Female|Mixed glioma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|655|223491138|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|599|226145243|Male and Female|Mixed glioma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Mixed glioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|613|226772500|Male and Female|Mixed glioma|2011|0.2|0.3|0.3
20+|0.5|0.6|0.6|Benign/Borderline|1171|211050944|Male and Female|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|1322|211050944|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.7|0.7|Benign/Borderline|1472|213511339|Male and Female|Neoplasm, unspecified|2005|0.7|0.7|0.7
20+|0.6|0.7|0.6|Malignant|1336|213511339|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1373|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1299|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1382|218481776|Male and Female|Neoplasm, unspecified|2007|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|1225|218481776|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|6902|1108144392|Male and Female|Neoplasm, unspecified|2007-2011|0.6|0.6|0.6
20+|0.5|0.6|0.6|Malignant|6394|1108144392|Male and Female|Neoplasm, unspecified|2007-2011|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1390|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1379|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1472|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1418|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1370|226145243|Male and Female|Neoplasm, unspecified|2010|0.6|0.6|0.6
20+|0.5|0.6|0.5|Malignant|1229|226145243|Male and Female|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|1316|226772500|Male and Female|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.5|0.5|0.5|Malignant|1209|226772500|Male and Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|2.1|2.3|2.2|Benign/Borderline|4691|211050944|Male and Female|Nerve sheath, benign and malignant|2004|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5287|213511339|Male and Female|Nerve sheath, benign and malignant|2005|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|51|213511339|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|5349|216055494|Male and Female|Nerve sheath, benign and malignant|2006|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5362|218481776|Male and Female|Nerve sheath, benign and malignant|2007|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.3|2.3|2.3|Benign/Borderline|26594|1108144392|Male and Female|Nerve sheath, benign and malignant|2007-2011|2.4|2.4|2.4
20+|0.0|0.0|0.0|Malignant|223|1108144392|Male and Female|Nerve sheath, benign and malignant|2007-2011|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5386|220975702|Male and Female|Nerve sheath, benign and malignant|2008|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|49|220975702|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|5579|223491138|Male and Female|Nerve sheath, benign and malignant|2009|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|5209|226145243|Male and Female|Nerve sheath, benign and malignant|2010|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|44|226145243|Male and Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.1|2.2|2.2|Benign/Borderline|5174|226772500|Male and Female|Nerve sheath, benign and malignant|2011|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|34|226772500|Male and Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|52|218481776|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|1108144392|Male and Female|Neuroepithelial|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|236|1108144392|Male and Female|Neuroepithelial|2007-2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|43|223491138|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|53|226145243|Male and Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|44|226772500|Male and Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|307|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|364|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|54|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|371|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|42|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|376|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|46|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|2052|1108144392|Male and Female|Neuronal/glial, neuronal|2007-2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|199|1108144392|Male and Female|Neuronal/glial, neuronal|2007-2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|409|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|47|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|427|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|38|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|455|226145243|Male and Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|33|226145243|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|396|226772500|Male and Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|36|226772500|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|818|211050944|Male and Female|Oligodendroglioma|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.4|Malignant|776|213511339|Male and Female|Oligodendroglioma|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|820|216055494|Male and Female|Oligodendroglioma|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.4|Malignant|786|218481776|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Oligodendroglioma|2007-2011|~|~|~
20+|0.3|0.4|0.3|Malignant|3780|1108144392|Male and Female|Oligodendroglioma|2007-2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|738|220975702|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|800|223491138|Male and Female|Oligodendroglioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|766|226145243|Male and Female|Oligodendroglioma|2010|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|712|226772500|Male and Female|Oligodendroglioma|2011|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|146|211050944|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|50|211050944|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|149|213511339|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|62|213511339|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|151|216055494|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|56|216055494|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|165|218481776|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|71|218481776|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|852|1108144392|Male and Female|Other mesenchymal|2007-2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|371|1108144392|Male and Female|Other mesenchymal|2007-2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|197|220975702|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|93|220975702|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|188|223491138|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|72|223491138|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|166|226145243|Male and Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|64|226145243|Male and Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|138|226772500|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|72|226772500|Male and Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|271|211050944|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|303|213511339|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|307|216055494|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|300|218481776|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|1108144392|Male and Female|Pilocytic astrocytoma|2007-2011|~|~|~
20+|0.1|0.1|0.1|Malignant|1478|1108144392|Male and Female|Pilocytic astrocytoma|2007-2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|288|220975702|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|264|223491138|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226145243|Male and Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|322|226145243|Male and Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226772500|Male and Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|311|226772500|Male and Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|30|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|47|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|46|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|253|1108144392|Male and Female|Pineal parenchymal|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|205|1108144392|Male and Female|Pineal parenchymal|2007-2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|51|226145243|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|37|226145243|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|54|226772500|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|39|226772500|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|3.2|3.4|3.3|Benign/Borderline|7003|211050944|Male and Female|Pituitary|2004|3.2|3.4|3.3
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|3.6|3.8|3.7|Benign/Borderline|7900|213511339|Male and Female|Pituitary|2005|3.6|3.8|3.7
20+|0.0|0.0|0.0|Malignant|37|213511339|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|8641|216055494|Male and Female|Pituitary|2006|3.9|4.1|4.0
20+|0.0|0.0|0.0|Malignant|29|216055494|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|4.0|4.2|4.1|Benign/Borderline|9010|218481776|Male and Female|Pituitary|2007|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|32|218481776|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.4|4.4|4.4|Benign/Borderline|49117|1108144392|Male and Female|Pituitary|2007-2011|4.4|4.5|4.4
20+|0.0|0.0|0.0|Malignant|115|1108144392|Male and Female|Pituitary|2007-2011|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|9687|220975702|Male and Female|Pituitary|2008|4.3|4.5|4.4
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008|~|~|~
20+|4.5|4.7|4.6|Benign/Borderline|10438|223491138|Male and Female|Pituitary|2009|4.6|4.8|4.7
20+|0.0|0.0|0.0|Malignant|19|223491138|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|4.4|4.5|4.5|Benign/Borderline|10176|226145243|Male and Female|Pituitary|2010|4.4|4.6|4.5
20+|0.0|0.0|0.0|Malignant|28|226145243|Male and Female|Pituitary|2010|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|10006|226772500|Male and Female|Pituitary|2011|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|25|226772500|Male and Female|Pituitary|2011|0.0|0.0|0.0
20+|15.5|15.9|15.7|Benign/Borderline|33348|211050944|Male and Female|Total|2004|15.6|16.0|15.8
20+|9.0|9.2|9.1|Malignant|19306|211050944|Male and Female|Total|2004|9.0|9.3|9.1
20+|17.4|17.8|17.6|Benign/Borderline|37954|213511339|Male and Female|Total|2005|17.6|18.0|17.8
20+|9.0|9.2|9.1|Malignant|19593|213511339|Male and Female|Total|2005|9.0|9.3|9.2
20+|18.1|18.4|18.3|Benign/Borderline|40022|216055494|Male and Female|Total|2006|18.3|18.7|18.5
20+|8.8|9.1|9.0|Malignant|19694|216055494|Male and Female|Total|2006|9.0|9.2|9.1
20+|18.4|18.7|18.5|Benign/Borderline|41302|218481776|Male and Female|Total|2007|18.7|19.1|18.9
20+|8.8|9.1|9.0|Malignant|19978|218481776|Male and Female|Total|2007|9.0|9.3|9.1
20+|19.2|19.4|19.3|Benign/Borderline|220199|1108144392|Male and Female|Total|2007-2011|19.8|20.0|19.9
20+|8.7|8.8|8.8|Malignant|100690|1108144392|Male and Female|Total|2007-2011|9.0|9.1|9.1
20+|19.2|19.5|19.3|Benign/Borderline|43799|220975702|Male and Female|Total|2008|19.6|20.0|19.8
20+|8.9|9.1|9.0|Malignant|20398|220975702|Male and Female|Total|2008|9.1|9.4|9.2
20+|20.1|20.4|20.3|Benign/Borderline|46597|223491138|Male and Female|Total|2009|20.7|21.0|20.8
20+|8.7|9.0|8.9|Malignant|20510|223491138|Male and Female|Total|2009|9.1|9.3|9.2
20+|19.1|19.4|19.3|Benign/Borderline|45046|226145243|Male and Female|Total|2010|19.7|20.1|19.9
20+|8.5|8.7|8.6|Malignant|20327|226145243|Male and Female|Total|2010|8.9|9.1|9.0
20+|18.7|19.1|18.9|Benign/Borderline|44500|226772500|Male and Female|Total|2011|19.4|19.8|19.6
20+|8.3|8.5|8.4|Malignant|20076|226772500|Male and Female|Total|2011|8.7|9.0|8.9
20+|2.1|2.3|2.2|Benign/Borderline|4691|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5290|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|51|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|5351|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5364|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.3|2.3|2.3|Benign/Borderline|26614|1108144392|Male and Female|Tumors of Cranial and Spinal Nerves|2007-2011|2.4|2.4|2.4
20+|0.0|0.0|0.0|Malignant|223|1108144392|Male and Female|Tumors of Cranial and Spinal Nerves|2007-2011|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5390|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|49|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|5585|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|5212|226145243|Male and Female|Tumors of Cranial and Spinal Nerves|2010|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|44|226145243|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.1|2.2|2.2|Benign/Borderline|5179|226772500|Male and Female|Tumors of Cranial and Spinal Nerves|2011|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|34|226772500|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|807|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.4|7.6|7.5|Malignant|15947|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.4|7.7|7.6
20+|0.4|0.5|0.4|Benign/Borderline|937|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.4
20+|7.3|7.6|7.5|Malignant|16117|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.4|7.7|7.5
20+|0.4|0.5|0.5|Benign/Borderline|1000|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.5
20+|7.3|7.5|7.4|Malignant|16311|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.4|7.7|7.5
20+|0.4|0.5|0.4|Benign/Borderline|971|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|7.3|7.6|7.5|Malignant|16640|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|5209|1108144392|Male and Female|Tumors of Neuroepthelial Tissue|2007-2011|0.5|0.5|0.5
20+|7.3|7.4|7.3|Malignant|84012|1108144392|Male and Female|Tumors of Neuroepthelial Tissue|2007-2011|7.5|7.6|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1028|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.5
20+|7.3|7.5|7.4|Malignant|16898|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.5|7.8|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1062|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.5
20+|7.3|7.5|7.4|Malignant|17095|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.5|7.8|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1114|226145243|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.5|0.5
20+|7.1|7.3|7.2|Malignant|17031|226145243|Male and Female|Tumors of Neuroepthelial Tissue|2010|7.4|7.6|7.5
20+|0.4|0.5|0.5|Benign/Borderline|1063|226772500|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.4|0.5|0.5
20+|7.0|7.2|7.1|Malignant|16823|226772500|Male and Female|Tumors of Neuroepthelial Tissue|2011|7.3|7.5|7.4
20+|3.4|3.6|3.5|Benign/Borderline|7375|211050944|Male and Female|Tumors of Sellar Region|2004|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.8|4.0|3.9|Benign/Borderline|8307|213511339|Male and Female|Tumors of Sellar Region|2005|3.8|4.0|3.9
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.1|4.2|4.2|Benign/Borderline|9021|216055494|Male and Female|Tumors of Sellar Region|2006|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|31|216055494|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|9414|218481776|Male and Female|Tumors of Sellar Region|2007|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|32|218481776|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.5|4.6|4.6|Benign/Borderline|51139|1108144392|Male and Female|Tumors of Sellar Region|2007-2011|4.6|4.7|4.6
20+|0.0|0.0|0.0|Malignant|120|1108144392|Male and Female|Tumors of Sellar Region|2007-2011|0.0|0.0|0.0
20+|4.5|4.6|4.5|Benign/Borderline|10097|220975702|Male and Female|Tumors of Sellar Region|2008|4.5|4.7|4.6
20+|~|~|~|Malignant|~|220975702|Male and Female|Tumors of Sellar Region|2008|~|~|~
20+|4.7|4.9|4.8|Benign/Borderline|10854|223491138|Male and Female|Tumors of Sellar Region|2009|4.8|4.9|4.9
20+|0.0|0.0|0.0|Malignant|20|223491138|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|4.5|4.7|4.6|Benign/Borderline|10594|226145243|Male and Female|Tumors of Sellar Region|2010|4.6|4.8|4.7
20+|0.0|0.0|0.0|Malignant|28|226145243|Male and Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|4.5|4.6|4.5|Benign/Borderline|10389|226772500|Male and Female|Tumors of Sellar Region|2011|4.5|4.7|4.6
20+|0.0|0.0|0.0|Malignant|27|226772500|Male and Female|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|8.8|9.0|8.9|Benign/Borderline|18907|211050944|Male and Female|Tumors of the Meninges|2004|8.8|9.1|9.0
20+|0.2|0.3|0.2|Malignant|494|211050944|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|9.8|10.1|9.9|Benign/Borderline|21430|213511339|Male and Female|Tumors of the Meninges|2005|9.9|10.2|10.0
20+|0.2|0.3|0.2|Malignant|499|213511339|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|10.2|10.5|10.3|Benign/Borderline|22684|216055494|Male and Female|Tumors of the Meninges|2006|10.4|10.6|10.5
20+|0.2|0.2|0.2|Malignant|463|216055494|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|10.4|10.6|10.5|Benign/Borderline|23500|218481776|Male and Female|Tumors of the Meninges|2007|10.6|10.9|10.8
20+|0.2|0.3|0.2|Malignant|522|218481776|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|10.9|11.0|10.9|Benign/Borderline|125715|1108144392|Male and Female|Tumors of the Meninges|2007-2011|11.3|11.4|11.3
20+|0.2|0.2|0.2|Malignant|2132|1108144392|Male and Female|Tumors of the Meninges|2007-2011|0.2|0.2|0.2
20+|10.9|11.1|11.0|Benign/Borderline|25087|220975702|Male and Female|Tumors of the Meninges|2008|11.2|11.5|11.4
20+|0.2|0.2|0.2|Malignant|455|220975702|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|11.4|11.6|11.5|Benign/Borderline|26682|223491138|Male and Female|Tumors of the Meninges|2009|11.8|12.1|11.9
20+|0.2|0.2|0.2|Malignant|416|223491138|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|10.7|11.0|10.9|Benign/Borderline|25700|226145243|Male and Female|Tumors of the Meninges|2010|11.2|11.5|11.4
20+|0.1|0.2|0.2|Malignant|370|226145243|Male and Female|Tumors of the Meninges|2010|0.1|0.2|0.2
20+|10.5|10.8|10.7|Benign/Borderline|25402|226772500|Male and Female|Tumors of the Meninges|2011|11.1|11.3|11.2
20+|0.1|0.2|0.2|Malignant|376|226772500|Male and Female|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|0.7|0.8|0.7|Benign/Borderline|1527|211050944|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.7
20+|0.6|0.7|0.6|Malignant|1335|211050944|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|0.9|0.9|Benign/Borderline|1927|213511339|Male and Female|Unclassified Tumors|2005|0.9|0.9|0.9
20+|0.6|0.7|0.6|Malignant|1351|213511339|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|1903|216055494|Male and Female|Unclassified Tumors|2006|0.8|0.9|0.9
20+|0.6|0.6|0.6|Malignant|1315|216055494|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.9|0.9|0.9|Benign/Borderline|1986|218481776|Male and Female|Unclassified Tumors|2007|0.9|0.9|0.9
20+|0.5|0.6|0.6|Malignant|1235|218481776|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.0|1.0|Benign/Borderline|11221|1108144392|Male and Female|Unclassified Tumors|2007-2011|1.0|1.0|1.0
20+|0.5|0.6|0.6|Malignant|6490|1108144392|Male and Female|Unclassified Tumors|2007-2011|0.6|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|2136|220975702|Male and Female|Unclassified Tumors|2008|0.9|1.0|1.0
20+|0.6|0.6|0.6|Malignant|1402|220975702|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|1.0|1.1|1.0|Benign/Borderline|2346|223491138|Male and Female|Unclassified Tumors|2009|1.0|1.1|1.0
20+|0.6|0.7|0.6|Malignant|1436|223491138|Male and Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.0|1.1|1.0|Benign/Borderline|2373|226145243|Male and Female|Unclassified Tumors|2010|1.0|1.1|1.0
20+|0.5|0.6|0.5|Malignant|1250|226145243|Male and Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|2414|226772500|Male and Female|Unclassified Tumors|2011|1.0|1.1|1.1
20+|0.5|0.5|0.5|Malignant|1233|226772500|Male and Female|Unclassified Tumors|2011|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|148|211050944|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|211050944|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|150|213511339|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|176|216055494|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|216055494|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|179|218481776|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|1043|1108144392|Male and Female|Unique astrocytoma variants|2007-2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|266|1108144392|Male and Female|Unique astrocytoma variants|2007-2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|195|220975702|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|54|220975702|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|216|223491138|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|223491138|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|227|226145243|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|44|226145243|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|232|226772500|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|55|226772500|Male and Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
